	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S84-PMC3156327	PMC3156327	4/2011	S84-PMC3156327	['allergic disease is ASSOCIATED with significant differences in this pattern of Immune Development: firstly, in the neonatal T Cell function and, secondly, in the Postnatal maturation PATTERNS.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 183)]	2	[('GO_0001822', 'kidney development', 79, 'immune development'), ('UBERON_0002405', 'immune system', 79, 'immune'), ('CL_0000084', 'T cell', 124, 'T cell'), ('GO_0007567', 'parturition', 162, 'postnatal')]	0	['allergic disease : firstly, neonatal cell and, secondly, postnatal maturation patterns.']
S134-PMC4377888	PMC4377888	3/2015	S134-PMC4377888	['Arcade formation is a period of rapid Nephron Formation and THEREFORE disruption of Kidney Development durign this CRITICAL window CAN have a PROFOUND IMPACT.']	[('PROBABLE_UNDERSTANDING', 60), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('GO_0006953', 'acute-phase response', 0, 'Arcade'), ('GO_0072006', 'nephron development', 38, 'nephron formation'), ('UBERON_0001285', 'nephron', 38, 'nephron'), ('GO_0001822', 'kidney development', 84, 'kidney development'), ('UBERON_0002113', 'kidney', 84, 'kidney')]	0	['arcade formation period rapid nephron formation  durign window impact.']
S71-PMC3227644	PMC3227644	11/2011	S71-PMC3227644	['HOWEVER, such EFFECTS were more modest than observed in Pregnancy which SUGGESTS the EFFECTS of the developmental environment on the female offspring were cryptic UNLESS challenged by the metabolic demands of Pregnancy.10.1371/journal.pone.0028282.g004\n\ncaption (fig): figure 4\noffspring phenotype and mrna Expression of Genes INVOLVED in Hepatic Gluconeogenesis and Ketogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('SUPERFICIAL_RELATIONSHIP', 327)]	7	[('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0010467', 'gene expression', 307, 'expression'), ('SO_0000704', 'gene', 321, 'genes'), ('GO_0007568', 'aging', 339, 'hepatic'), ('UBERON_0002107', 'liver', 339, 'hepatic'), ('GO_0006094', 'gluconeogenesis', 347, 'gluconeogenesis'), ('GO_0001822', 'kidney development', 367, 'ketogenesis')]	0	['however, pregnancy developmental environment female offspring cryptic metabolic pregnancy.10.1371/journal.pone.0028282.g004\n\ncaption (fig): figure 4\noffspring phenotype mrna expression genes hepatic gluconeogenesis .']
S174-PMC3534399	PMC3534399	10/2012	S174-PMC3534399	['in the event that NONE of the supplementation combinations under trial have a marked impact on Immune Development across the whole cohort, data obtained MAY help pinpoint specific vulnerable groups (such as women with low Pre-Pregnancy bmi’s for whom intervention MAY BE most efficacious), for FURTHER TARGETED RESEARCH.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 264), ('FUTURE_WORK', 294)]	4	[('GO_0001822', 'kidney development', 95, 'immune development'), ('UBERON_0002405', 'immune system', 95, 'immune'), ('GO_0007568', 'aging', 222, 'pre'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy')]	0	['event supplementation combinations marked  whole cohort, (such women pre-pregnancy bmi’s efficacious), research.']
S58-PMC4918713	PMC4918713	6/2015	S58-PMC4918713	['THERE IS EVIDENCE from Animal and Human studies of teratogenicity of natural and synthetic Retinoids through AFFECTING the Development Of Cephalic Neural-Crest Cells and their derivatives and perhaps INTERFERING with the Closure Of the Neural Tube.46\n\nFetal Organ Development\nid MAY also interfere with normal fetal Kidney Development by reducing Nephron number.39this MAY result in the OBSERVED ASSOCIATION between maternal id and high Blood pressure in the offspring AS Kidney Nephron number is an IMPORTANT DETERMINANT of Blood pressure.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 369), ('INCOMPLETE_EVIDENCE', 387), ('SUPERFICIAL_RELATIONSHIP', 396), ('PROBABLE_UNDERSTANDING', 469), ('IMPORTANT_CONSIDERATION', 500), ('SUPERFICIAL_RELATIONSHIP', 510)]	10	[('NCBITaxon_33208', 'Metazoa', 23, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_26537', 'retinoid', 91, 'retinoids'), ('GO_0048468', 'cell development', 123, 'development of ... cells'), ('UBERON_0001456', 'face', 138, 'cephalic'), ('UBERON_0002342', 'neural crest', 147, 'neural-crest'), ('GO_0043277', 'apoptotic cell clearance', 221, 'closure of ... neural tube'), ('UBERON_0001049', 'neural tube', 236, 'neural tube'), ('GO_0008618', '7-methylguanosine metabolic process', 252, 'Fetal'), ('GO_0048513', 'animal organ development', 258, 'Organ Development'), ('UBERON_0000033', 'head', 258, 'Organ'), ('GO_0001822', 'kidney development', 316, 'kidney development'), ('UBERON_0002113', 'kidney', 316, 'kidney'), ('UBERON_0001285', 'nephron', 347, 'nephron'), ('UBERON_0000178', 'blood', 437, 'blood'), ('UBERON_0002113', 'kidney', 472, 'kidney'), ('UBERON_0001285', 'nephron', 479, 'nephron'), ('UBERON_0000178', 'blood', 525, 'blood')]	0	['animal human teratogenicity natural synthetic retinoids cephalic neural-crest cells derivatives closure neural tube.46\n\nfetal organ development\nid normal fetal  reducing nephron number.39this result maternal id blood pressure offspring kidney nephron blood pressure.']
S26-PMC5716389	PMC5716389	9/2017	S26-PMC5716389	['KEY maternal nutrition/Nutrients and their POTENTIAL EFFECT on fetal Immunity and vaccine response.Nutrientrole in immunityfetal Immune deficitvaccines that MAY BE AFFECTED pem– building blocks of proteins and peptides– precursors for the Synthesis Of nitrogenous Hormones– substrates for the Production Of numerous Substances, including dna, Neurotransmitters, Vasodilators and Signaling Molecules– major Metabolic fuels for the Small Intestine and cells Of the Immune System– iugr causing reduced fetal Thymic function– neurological damage– anemia– impaired Blood flowall vaccineszinc– Fetal Growth and Development, Regulation Of Food– Intake, Development Of Immune System– Thymic atrophy– distortion of the Cell-Mediated Immune Response– impaired Mucosal integrityall vaccinesvitamin amaintaining the integrity of Mucosal Surfaces, Cell-Mediated and humoral Immune Responsesweakened Mucosal integrityoral vaccines like rota and oral polio more affected than nonoral vaccinesvitamin d– Promotion Of Th2 and Treg Signaling– Cell-Mediated and humoral Immune Responsesimpaired absorption of dietary Calcium and phosphorentus to support fetal growth and developmmore EFFECT on live attenuated than killed vaccinesvitamin cconnective Tissue growth and developmentprotect mother and fetus from oxidative stress– iugr– subcutaneous hemorrhage– defective collagen structureall vaccinesfolate– Cell Proliferation, Central Nervous System Cell Repair– appropriate epigenetic Expression of the Genome– Immune Development– Formation Of Red Blood Cells– impaired Immune System– neural defectslive vaccinesiodineproduction of Thyroid Hormonespoor Immune Responseall vaccinesiron– Oxygen binding, Transport, storage and sensingmetabolism Of Nutrients including Proteins, Lipids and Glucose– Mitochondrial Electron Transport and Atp Production dna synthesis, Antioxidative Reactions, immunity– iugr– impaired Immune Systemall vaccines\niugr:\xa0Intrauterine growth retardation; pem:\xa0protein energy malnutrition.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 164), ('SUPERFICIAL_RELATIONSHIP', 1165)]	6	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('GO_0007566', 'embryo implantation', 69, 'immunity'), ('CHEBI_7772', 'omeprazole', 99, 'NutrientRole'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('GO_0007416', 'synapse assembly', 239, 'synthesis of ... hormones'), ('GO_0043277', 'apoptotic cell clearance', 293, 'production of ... substances'), ('CHEBI_25512', 'neurotransmitter', 343, 'neurotransmitters'), ('GO_0042118', 'endothelial cell activation', 362, 'vasodilators'), ('CHEBI_62488', 'signalling molecule', 379, 'signaling molecules'), ('GO_0008152', 'metabolic process', 406, 'metabolic'), ('UBERON_0002108', 'small intestine', 430, 'small intestine'), ('CL_0000024', 'oogonial cell', 456, 'of'), ('UBERON_0002405', 'immune system', 463, 'immune system'), ('CL_0000034', 'stem cell', 470, 'system'), ('UBERON_0002370', 'thymus', 505, 'thymic'), ('UBERON_0000178', 'blood', 560, 'blood'), ('GO_0008618', '7-methylguanosine metabolic process', 588, 'Fetal'), ('GO_0008406', 'gonad development', 594, 'growth ... development'), ('GO_0006450', 'regulation of translational fidelity', 618, 'regulation of food'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0007631', 'feeding behavior', 638, 'Intake'), ('GO_0002206', 'gene conversion of immunoglobulin genes', 646, 'development of immune system'), ('UBERON_0002405', 'immune system', 661, 'immune system'), ('UBERON_0002370', 'thymus', 676, 'Thymic'), ('GO_0006968', 'cellular defense response', 710, 'cell-mediated immune response'), ('UBERON_0002405', 'immune system', 724, 'immune'), ('UBERON_0000344', 'mucosa', 750, 'mucosal'), ('UBERON_0000344', 'mucosa', 817, 'mucosal'), ('GO_0009986', 'cell surface', 825, 'surfaces'), ('GO_0098761', 'cellular response to interleukin-7', 835, 'cell-mediated ... immune responsesWeakened'), ('UBERON_0000344', 'mucosa', 886, 'mucosal'), ('GO_0007565', 'female pregnancy', 988, 'Promotion of'), ('GO_0042633', 'hair cycle', 1001, 'Th2 ...'), ('CL_0000901', 'Tr1 cell', 1009, 'Treg'), ('GO_0008036', 'diuretic hormone receptor activity', 1009, 'Treg signaling'), ('GO_0071321', 'cellular response to cGMP', 1025, 'Cell-mediated ... immune responsesImpaired'), ('UBERON_0002405', 'immune system', 1051, 'immune'), ('CHEBI_22313', 'alkaline earth metal atom', 1098, 'calcium'), ('UBERON_0000479', 'tissue', 1231, 'tissue'), ('GO_0008283', 'cell proliferation', 1387, 'Cell proliferation'), ('UBERON_0001017', 'central nervous system', 1407, 'central nervous system'), ('CL_0000047', 'neuronal stem cell', 1415, 'nervous system cell'), ('GO_0007267', 'cell-cell signaling', 1415, 'nervous system'), ('GO_0008219', 'cell death', 1430, 'cell repair'), ('GO_0010467', 'gene expression', 1466, 'expression'), ('SO_0001026', 'genome', 1484, 'genome'), ('GO_0001822', 'kidney development', 1492, 'Immune development'), ('GO_0048468', 'cell development', 1512, 'Formation of ... blood cells'), ('CL_0000232', 'erythrocyte', 1525, 'red blood cells'), ('UBERON_0000178', 'blood', 1529, 'blood'), ('UBERON_0002405', 'immune system', 1551, 'immune system'), ('CHEBI_71207', '(2Z,4E)-2-hydroxy-6-oxohexa-2,4-dienoic acid', 1613, 'thyroid hormonesPoor'), ('UBERON_0001478', 'teres major muscle', 1613, 'thyroid hormonesPoor'), ('GO_0002443', 'leukocyte mediated immunity', 1634, 'immune responseAll'), ('UBERON_0002405', 'immune system', 1634, 'immune'), ('CHEBI_33309', 'noble gas atom', 1667, 'Oxygen'), ('GO_0006409', 'tRNA export from nucleus', 1683, 'transport ... of nutrients'), ('CHEBI_33284', 'nutrient', 1727, 'nutrients'), ('GO_0007567', 'parturition', 1747, 'proteins'), ('CHEBI_18059', 'lipid', 1757, 'lipids'), ('CHEBI_17234', 'glucose', 1768, 'glucose'), ('GO_0005739', 'mitochondrion', 1777, 'Mitochondrial'), ('CHEBI_10545', 'electron', 1791, 'electron'), ('GO_0006809', 'nitric oxide biosynthetic process', 1800, 'transport'), ('GO_0006754', 'ATP biosynthetic process', 1814, 'ATP production'), ('GO_0019985', 'translesion synthesis', 1844, 'antioxidative reactions'), ('UBERON_0004204', 'outer medullary collecting duct', 1894, 'immune systemAll'), ('UBERON_0035108', 'temporalis fascia', 1926, 'Intrauterine')]	0	['key maternal nutrition/nutrients fetal immunity vaccine response.nutrientrole immunityfetal immune deficitvaccines pem– blocks proteins peptides– precursors synthesis nitrogenous hormones– production substances, dna, neurotransmitters, vasodilators signaling molecules– metabolic fuels intestine cells immune system– iugr fetal thymic function– neurological damage– anemia– blood flowall vaccineszinc– fetal development, food– intake, immune system– thymic atrophy– cell-mediated immune response– mucosal integrityall vaccinesvitamin amaintaining integrity mucosal surfaces, cell-mediated humoral immune responsesweakened mucosal integrityoral vaccines rota oral polio nonoral vaccinesvitamin d– th2 treg signaling– cell-mediated humoral immune responsesimpaired absorption dietary calcium phosphorentus fetal developmmore live attenuated killed vaccinesvitamin cconnective tissue developmentprotect mother fetus oxidative stress– iugr– subcutaneous hemorrhage– defective collagen structureall vaccinesfolate– cell proliferation, central nervous system cell repair– epigenetic expression genome– formation red blood cells– immune system– neural defectslive vaccinesiodineproduction thyroid hormonespoor immune responseall vaccinesiron– oxygen binding, transport, storage sensingmetabolism nutrients proteins, lipids glucose– mitochondrial electron transport atp production dna synthesis, antioxidative reactions, immunity– iugr– immune systemall vaccines\niugr:\xa0intrauterine retardation; pem:\xa0protein energy malnutrition.']
S170-PMC4377888	PMC4377888	3/2015	S170-PMC4377888	['these molecular changes were ACCOMPANIED with increased Apoptosis in the Nephrogenic zone (the area of active Nephrogenesis) of the Kidney [115].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('GO_0006915', 'apoptotic process', 56, 'apoptosis'), ('GO_0001822', 'kidney development', 73, 'nephrogenic'), ('GO_0001822', 'kidney development', 110, 'nephrogenesis'), ('UBERON_0002113', 'kidney', 132, 'kidney')]	0	['molecular changes apoptosis  zone (the kidney [115].']
S209-PMC4377888	PMC4377888	3/2015	S209-PMC4377888	['the removal of Dicer lead TO elevated Apoptosis and premature termination of Nephrogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26)]	1	[('CHEBI_37958', 'dye', 15, 'Dicer'), ('PR_000006305', 'dermcidin', 15, 'Dicer'), ('GO_0006915', 'apoptotic process', 38, 'apoptosis'), ('GO_0001822', 'kidney development', 77, 'nephrogenesis')]	0	['removal dicer elevated apoptosis premature termination .']
S202-PMC4789467	PMC4789467	3/2016	S202-PMC4789467	['dysregulated Glial Cell Line-Derived Neurotrophic Factor (Gdnf) and Mitogen-activated protein kinase-Extracellular signal-Regulated protein kinase (mapk–erk) signaling and increased Apoptosis (henry et al.,2010; tafti et al.,2011), IN conjunction with elevated vasopressin (sebaai et al.,2002b), angiotensin ii and Aldosterone levels (Ang Ii; riviere et al.,2005), MAY BE key UNDERLYING FACTORS in the pathogenesis of reduced offspring Nephrogenesis and programmed Hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 376), ('SUPERFICIAL_RELATIONSHIP', 387)]	4	[('CL_0000125', 'glial cell', 13, 'glial cell'), ('PR_000007939', 'glial fibrillary acidic protein', 13, 'glial cell line-derived neurotrophic factor'), ('PR_000007939', 'glial fibrillary acidic protein', 58, 'GDNF'), ('CHEBI_52290', 'mitogen', 68, 'mitogen'), ('GO_0005576', 'extracellular region', 101, 'extracellular'), ('GO_0065007', 'biological regulation', 122, 'regulated'), ('GO_0006915', 'apoptotic process', 182, 'apoptosis'), ('CHEBI_27584', 'aldosterone', 315, 'aldosterone'), ('PR_000003539', 'ATP-binding cassette sub-family A member 12', 335, 'Ang II'), ('GO_0001822', 'kidney development', 436, 'nephrogenesis'), ('GO_0007599', 'hemostasis', 465, 'hypertension')]	0	['dysregulated glial cell line-derived neurotrophic (gdnf) mitogen-activated protein kinase-extracellular signal-regulated protein kinase (mapk–erk) signaling apoptosis (henry et al.,2010; tafti et al.,2011), elevated vasopressin (sebaai et al.,2002b), angiotensin ii aldosterone levels (ang ii; riviere et al.,2005), pathogenesis offspring  programmed hypertension.']
S112-PMC3600625	PMC3600625	2/2013	S112-PMC3600625	['in experimental studies it HAS BEEN demonstrated that hypertensive offspring CAN be produced by a range of Nutrient restrictions provided during Pregnancy in a variety of species.37–39one of the POSTULATED mechanisms is a reduction in Kidney Nephron number, which MAY lead to hyperfiltration and ultimately to glomerulosclerosis.40,41in Humans, Nephrogenesis occurs between weeks 8 and 36 of Gestation with no POTENTIAL for increase after Birth, SUGGESTING that Pregnancy MAY BE acritical window for development.40HOWEVER, data from Human studies on the IMPACT of environmental exposures during Pregnancy, including diet, are SCARCE with the MAJORITY of EVIDENCE derived from studies of Birth weight ASSOCIATIONS.2,3,42\nthe health EFFECTS of chronic Arsenic exposure HAVE BEEN extensively studied, PARTICULARLY in areas such as bangladesh where contamination of drinking Water is often particularly high, and HAVE BEEN FOUND to increase all-cause10,43and Cardiovascular-related mortality.10recent data from the national Health and nutrition examination survey (nhanes) in the us FOUND no association in a cross-sectional analysis between Urinary Arsenic (much lower concentrations, APPROXIMATELY 10% of the present study levels) or cadmium levels and hypertension in us Adults.44,45there was, HOWEVER, SOME EVIDENCE that Blood cadmium levels MAY BE ASSOCIATED with raised diastolic, BUT not systolic, Blood pressure.45in a RECENT systematic REVIEW of the EFFECT of Arsenic exposure on Cardiovascular RISK, the authors REPORTED that the MAJORITY of studies used ecological exposure assessment (drinking Water) and that most were not of sufficient quality to allow for a definitive INTERPRETATION.11\none of the strengths of the CURRENT study was the assessment of Arsenic and cadmium at the Individual level IN CONTRAST TO ecological exposure assessment utilized by MANY STUDIES in this field.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 410), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 472), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 512), ('SUPERFICIAL_RELATIONSHIP', 554), ('INCOMPLETE_EVIDENCE', 626), ('PROBABLE_UNDERSTANDING', 642), ('INCOMPLETE_EVIDENCE', 654), ('SUPERFICIAL_RELATIONSHIP', 700), ('SUPERFICIAL_RELATIONSHIP', 731), ('INCOMPLETE_EVIDENCE', 767), ('IMPORTANT_CONSIDERATION', 798), ('INCOMPLETE_EVIDENCE', 909), ('INCOMPLETE_EVIDENCE', 1079), ('INCOMPLETE_EVIDENCE', 1182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1293), ('ANOMALY_CURIOUS_FINDING', 1293), ('INCOMPLETE_EVIDENCE', 1302), ('INCOMPLETE_EVIDENCE', 1342), ('SUPERFICIAL_RELATIONSHIP', 1349), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1383), ('INCOMPLETE_EVIDENCE', 1423), ('INCOMPLETE_EVIDENCE', 1441), ('SUPERFICIAL_RELATIONSHIP', 1455), ('IMPORTANT_CONSIDERATION', 1500), ('INCOMPLETE_EVIDENCE', 1518), ('PROBABLE_UNDERSTANDING', 1536), ('INCOMPLETE_EVIDENCE', 1680), ('QUESTION_ANSWERED_BY_THIS_WORK', 1726), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1806), ('INCOMPLETE_EVIDENCE', 1864)]	35	[('CHEBI_33284', 'nutrient', 107, 'nutrient'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0002113', 'kidney', 235, 'kidney'), ('UBERON_0001285', 'nephron', 242, 'nephron'), ('NCBITaxon_9606', 'Homo sapiens', 337, 'humans'), ('GO_0001822', 'kidney development', 345, 'nephrogenesis'), ('GO_0007565', 'female pregnancy', 392, 'gestation'), ('GO_0007567', 'parturition', 439, 'birth'), ('GO_0007565', 'female pregnancy', 462, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 533, 'human'), ('GO_0007565', 'female pregnancy', 595, 'pregnancy'), ('GO_0007567', 'parturition', 687, 'birth'), ('CHEBI_27563', 'arsenic atom', 750, 'arsenic'), ('CHEBI_15377', 'water', 871, 'water'), ('UBERON_0004535', 'cardiovascular system', 955, 'cardiovascular'), ('UBERON_0000925', 'endoderm', 1020, 'Health'), ('UBERON_0001088', 'urine', 1138, 'urinary'), ('CHEBI_27563', 'arsenic atom', 1146, 'arsenic'), ('UBERON_0007023', 'adult organism', 1270, 'adults'), ('UBERON_0000178', 'blood', 1321, 'blood'), ('UBERON_0000178', 'blood', 1401, 'blood'), ('CHEBI_27563', 'arsenic atom', 1465, 'arsenic'), ('UBERON_0004535', 'cardiovascular system', 1485, 'cardiovascular'), ('CHEBI_15377', 'water', 1602, 'water'), ('CHEBI_27563', 'arsenic atom', 1762, 'arsenic'), ('NCBITaxon_1', 'root', 1789, 'individual')]	0	['hypertensive offspring nutrient pregnancy species.37–39one mechanisms reduction kidney nephron number, hyperfiltration glomerulosclerosis.40,41in humans,  occurs weeks 8 36 gestation increase birth, pregnancy acritical window development.40however, human environmental exposures pregnancy, diet, birth associations.2,3,42\nthe chronic arsenic exposure extensively studied, bangladesh drinking water high, increase all-cause10,43and cardiovascular-related mortality.10recent national nutrition survey (nhanes) us cross-sectional urinary arsenic (much concentrations, 10% levels) cadmium levels hypertension us adults.44,45there was, however, blood cadmium levels diastolic, systolic, blood pressure.45in arsenic exposure cardiovascular risk, authors ecological exposure (drinking water) interpretation.11\none arsenic cadmium individual ecological exposure utilized field.']
S103-PMC4172064	PMC4172064	9/2014	S103-PMC4172064	['follow-up Animal studies PINPOINTED the mechanism UNDERLYING this maternal EFFECT on Immune Development in their offspring as low-intensity Innate Immune Responses to microbial products in inhaled barn dust, which result in indirect attenuation of POTENTIALLY pro-inflammatory tlr functions in the maternal Decidua (103), LIKELY operating via a Bone Marrow-Placental axis (104).']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 75), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 322)]	5	[('NCBITaxon_33208', 'Metazoa', 10, 'animal'), ('GO_0001822', 'kidney development', 85, 'immune development'), ('UBERON_0002405', 'immune system', 85, 'immune'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 140, 'innate immune responses'), ('UBERON_0002405', 'immune system', 147, 'immune'), ('UBERON_0002450', 'decidua', 307, 'decidua'), ('UBERON_0002371', 'bone marrow', 345, 'bone marrow'), ('UBERON_0001987', 'placenta', 357, 'placental')]	0	['follow-up animal maternal  offspring low-intensity innate immune responses microbial products inhaled barn dust, result attenuation pro-inflammatory tlr functions maternal decidua (103), via bone marrow-placental (104).']
S157-PMC3458940	PMC3458940	9/2012	S157-PMC3458940	['apart from Kidney Development and OTHER PREVIOUSLY REPORTED tra/rar-DEPENDENT Biological Processes[7],[37], these Genes are also INVOLVED in responses to external stimuli, including oxygen levels, hormones, and chemicals, CONSISTENT with the functions of Cd Cells to withstand the highly variable oxygen levels, particularly in the Medulla, as well as in Regulating Water and Solute Transport.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 222)]	6	[('GO_0001822', 'kidney development', 11, 'kidney development'), ('UBERON_0002113', 'kidney', 11, 'kidney'), ('GO_0008150', 'biological_process', 78, 'biological processes'), ('SO_0000704', 'gene', 114, 'genes'), ('CL_0000051', 'common lymphoid progenitor', 255, 'CD cells'), ('UBERON_0000958', 'medulla of organ', 332, 'medulla'), ('GO_0065007', 'biological regulation', 355, 'regulating'), ('CHEBI_15377', 'water', 366, 'water'), ('GO_0007605', 'sensory perception of sound', 366, 'water ...'), ('GO_0006814', 'sodium ion transport', 376, 'solute transport')]	0	['apart  tra/rar-dependent biological processes[7],[37], genes responses external stimuli, oxygen levels, hormones, chemicals, functions cd cells withstand oxygen levels, medulla, water solute transport.']
S82-PMC3868354	PMC3868354	4/2013	S82-PMC3868354	['each is presented separately HERE because each tracks a slightly different Biological Process: while age marks the passage of time, with which the probability of maturational events increases, Gynecological age signifies distance from a threshold Reproductive Event in an Individual’s unique maturational history.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29)]	1	[('GO_0008150', 'biological_process', 75, 'biological process'), ('GO_0008346', 'larval walking behavior', 193, 'gynecological'), ('GO_0001822', 'kidney development', 247, 'reproductive event'), ('NCBITaxon_1', 'root', 272, 'individual')]	0	['separately biological process: age marks passage time, maturational events increases, gynecological age signifies distance  individual’s maturational history.']
S0-PMC2409299	PMC2409299	5/2008	S0-PMC2409299	['Birth Season and environmental INFLUENCES on Blood Leucocyte and Lymphocyte subpopulations in rural gambian infants\n\nabstract\n\nbackground\nin rural gambia, Birth season PREDICTS infection-RELATED Adult mortality, PROVIDING EVIDENCE that seasonal FACTORS in early Life MAY programme Immune Development.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 187), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 245), ('INCOMPLETE_EVIDENCE', 267)]	7	[('GO_0007599', 'hemostasis', 0, 'Birth season'), ('CL_0000081', 'blood cell', 45, 'blood leucocyte'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CL_0000542', 'lymphocyte', 65, 'lymphocyte'), ('GO_0007567', 'parturition', 155, 'birth'), ('UBERON_0007023', 'adult organism', 195, 'adult'), ('UBERON_0000104', 'life cycle', 262, 'life'), ('GO_0001822', 'kidney development', 281, 'immune development'), ('UBERON_0002405', 'immune system', 281, 'immune')]	0	['birth season environmental blood leucocyte lymphocyte subpopulations rural gambian infants\n\nabstract\n\nbackground\nin rural gambia, birth season infection-related adult mortality, seasonal life programme .']
S19-PMC3482177	PMC3482177	10/2012	S19-PMC3482177	['a NUMBER OF Rodent STUDIES INDICATE that the imposition of iron deficiency prior to and during Pregnancy has long-term EFFECTS upon the resulting offspring, with REPORTS of high Blood pressure[11],[14]–[16], impaired Nephrogenesis[17]and altered Glucose handling[16].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 162)]	5	[('NCBITaxon_33208', 'Metazoa', 12, 'rodent'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('UBERON_0000178', 'blood', 178, 'blood'), ('GO_0001822', 'kidney development', 217, 'nephrogenesis'), ('CHEBI_17234', 'glucose', 246, 'glucose')]	0	['rodent imposition iron pregnancy long-term resulting offspring, blood pressure[11],[14]–[16], [17]and altered glucose handling[16].']
S1-PMC3749995	PMC3749995	8/2013	S1-PMC3749995	['high Salt Intake LEADS to high Blood pressure, EVEN when occurring prior to Birth – a mechanism PURPORTED to reside in altered Kidney Development and later function.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('ANOMALY_CURIOUS_FINDING', 47), ('INCOMPLETE_EVIDENCE', 96)]	3	[('CHEBI_24866', 'salt', 5, 'salt'), ('GO_0007631', 'feeding behavior', 10, 'intake'), ('UBERON_0000178', 'blood', 31, 'blood'), ('GO_0007567', 'parturition', 76, 'birth'), ('GO_0001822', 'kidney development', 127, 'kidney development'), ('UBERON_0002113', 'kidney', 127, 'kidney')]	0	['high salt intake blood pressure, occurring birth reside altered  function.']
S97-PMC4730270	PMC4730270	12/2015	S97-PMC4730270	['normalization of Blood pressure was ACCOMPANIED by the normalization of Nephron number, SUGGESTING that Prenatal Dexamethasone exposure PRIMARILY inhibits Nephrogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 136)]	3	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001285', 'nephron', 72, 'nephron'), ('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('CHEBI_41879', 'dexamethasone', 113, 'dexamethasone'), ('GO_0001822', 'kidney development', 155, 'nephrogenesis')]	0	['normalization blood pressure nephron number, prenatal dexamethasone exposure inhibits .']
S59-PMC4918713	PMC4918713	6/2015	S59-PMC4918713	['Nephron number is established during Kidney Development, beyond which point the number cannot be increased.47low Nephron number reduces the surface area available for filtration, and THEREFORE LIMITS the ability of the Kidney to Excrete sodium and maintain normal Extracellular Fluid volume and Blood pressure.4849EXPANDING on their EARLIER work with the wistar id MODEL, lisle et al35have INVESTIGATED the EFFECT of maternal id on the Renal morphology of the Adult offspring in Rats.']	[('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 333), ('INCOMPLETE_EVIDENCE', 365), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('SUPERFICIAL_RELATIONSHIP', 407)]	7	[('UBERON_0001285', 'nephron', 0, 'Nephron'), ('GO_0001822', 'kidney development', 37, 'kidney development'), ('UBERON_0002113', 'kidney', 37, 'kidney'), ('UBERON_0001285', 'nephron', 113, 'nephron'), ('UBERON_0002113', 'kidney', 219, 'kidney'), ('GO_0007588', 'excretion', 229, 'excrete'), ('GO_0005576', 'extracellular region', 264, 'extracellular'), ('UBERON_0000124', 'epineurium', 264, 'extracellular'), ('UBERON_0006314', 'bodily fluid', 278, 'fluid'), ('UBERON_0000178', 'blood', 295, 'blood'), ('UBERON_0002113', 'kidney', 436, 'renal'), ('UBERON_0007023', 'adult organism', 460, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 479, 'rats')]	0	['nephron increased.47low nephron reduces surface filtration, ability kidney excrete sodium maintain normal extracellular fluid volume blood pressure.4849expanding wistar id model, lisle et al35have maternal id renal morphology adult offspring rats.']
S136-PMC5837564	PMC5837564	4/2017	S136-PMC5837564	['reports on secular trends DESCRIBE declining mortality trends;1,12,13intergenerational and demographic transition EFFECTS on growth14,15and survival;16reductions in diarrhoea rates;17declining malaria rates.11\nmajor research findings include: INSIGHTS into season of Birth or Conception EFFECTS on mortality;18immune outcomes19and Dna Methylation;20effects of Pregnancy supplementation on low birthweight;21increased understanding of growth faltering; identification of CRITICAL windows beyond the ‘first 1000 days’ for POSSIBLE Nutritional interventions to address stunting;22lack of ANTICIPATED BENEFITS of Calcium supplementation in children and Pregnant mothers with a very low calcium intake, with identification of UNEXPECTED, POSSIBLY adverse, long-term Skeletal effects;23–25the use of Muac to identify infants at INCREASED RISK of death in lmic;26and the efficacy of hepatitis b vaccination after 24 years of follow-up.27\nmore RECENT developments with respect to the kwlps cohort are covered by the following publications on: early nutrition and Immune Development via a birth cohort followed up since 2010 (the enid trial);28life course nutrition and health, including Immune/inflammatory outcomes29and Cognitive Development;30the ROLE of the iron-hepcidin axis in infection;31,32and seasonal EFFECTS on Blood Cell composition.33\n\nWHAT are the main STRENGTHS and weaknesses?']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 243), ('SUPERFICIAL_RELATIONSHIP', 287), ('IMPORTANT_CONSIDERATION', 470), ('INCOMPLETE_EVIDENCE', 520), ('INCOMPLETE_EVIDENCE', 585), ('IMPORTANT_CONSIDERATION', 597), ('ANOMALY_CURIOUS_FINDING', 721), ('INCOMPLETE_EVIDENCE', 733), ('IMPORTANT_CONSIDERATION', 822), ('INCOMPLETE_EVIDENCE', 936), ('SUPERFICIAL_RELATIONSHIP', 1241), ('SUPERFICIAL_RELATIONSHIP', 1303), ('EXPLICIT_QUESTION', 1341), ('IMPORTANT_CONSIDERATION', 1359), ('EXPLICIT_QUESTION', 1383)]	17	[('GO_0007567', 'parturition', 267, 'birth'), ('GO_0007620', 'copulation', 276, 'conception'), ('GO_0006306', 'DNA methylation', 331, 'DNA methylation'), ('GO_0007565', 'female pregnancy', 360, 'pregnancy'), ('CHEBI_7495', 'nefazodone hydrochloride', 529, 'nutritional'), ('CHEBI_22313', 'alkaline earth metal atom', 609, 'calcium'), ('GO_0007565', 'female pregnancy', 649, 'pregnant'), ('UBERON_0004288', 'skeleton', 761, 'skeletal'), ('CHEBI_34845', 'metipranolol hydrochloride', 794, 'MUAC'), ('GO_0001822', 'kidney development', 1055, 'immune development'), ('UBERON_0002405', 'immune system', 1055, 'immune'), ('UBERON_0002405', 'immune system', 1179, 'immune'), ('GO_0050787', 'detoxification of mercury ion', 1213, 'cognitive development'), ('CL_0000081', 'blood cell', 1314, 'blood cell'), ('UBERON_0000178', 'blood', 1314, 'blood')]	0	['reports secular declining mortality trends;1,12,13intergenerational demographic transition growth14,15and survival;16reductions diarrhoea rates;17declining malaria rates.11\nmajor include: season birth mortality;18immune outcomes19and dna methylation;20effects pregnancy supplementation birthweight;21increased faltering; ‘first 1000 days’ nutritional stunting;22lack calcium supplementation children pregnant mothers calcium intake, unexpected, adverse, long-term skeletal effects;23–25the muac infants death lmic;26and hepatitis b vaccination 24 follow-up.27\nmore developments respect kwlps covered following publications on: nutrition  via birth followed 2010 (the enid trial);28life course nutrition health, immune/inflammatory outcomes29and cognitive development;30the iron-hepcidin infection;31,32and seasonal blood cell composition.33\n\nwhat main weaknesses?']
S23-PMC3471827	PMC3471827	10/2012	S23-PMC3471827	['we conclude that ttp is ESSENTIAL for early Brain and Axis Development.']	[('IMPORTANT_CONSIDERATION', 24)]	1	[('GO_0001822', 'kidney development', 44, 'brain ... axis development'), ('UBERON_0000955', 'brain', 44, 'brain')]	0	['ttp  .']
S145-PMC3471827	PMC3471827	10/2012	S145-PMC3471827	['we conclude that ttp is ESSENTIAL for early Brain and Axis Development, LIKELY because it delivers Α-Tocopherol to the developing Embryo.']	[('IMPORTANT_CONSIDERATION', 24), ('PROBABLE_UNDERSTANDING', 72)]	2	[('GO_0001822', 'kidney development', 44, 'brain ... axis development'), ('UBERON_0000955', 'brain', 44, 'brain'), ('CHEBI_27725', 'butin', 99, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 130, 'embryo')]	0	['ttp  delivers α-tocopherol embryo.']
S0-PMC3485340	PMC3485340	10/2012	S0-PMC3485340	['maternal vitamin c deficiency during Pregnancy persistently impairs hippocampal Neurogenesis in offspring of guinea pigs\n\nabstract\nwhile having the highest Vitamin C (vitc) concentrations in the body, specific functions of Vitc in the Brain HAVE ONLY RECENTLY BEEN acknowledged.']	[('IMPORTANT_CONSIDERATION', 241), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 251)]	3	[('GO_0007565', 'female pregnancy', 37, 'Pregnancy'), ('GO_0001822', 'kidney development', 80, 'Neurogenesis'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin C'), ('PR_000017299', 'VIP peptides', 223, 'VitC'), ('UBERON_0000955', 'brain', 235, 'brain')]	0	['maternal vitamin c pregnancy hippocampal  offspring guinea pigs\n\nabstract\nwhile vitamin c (vitc) concentrations body, functions vitc brain acknowledged.']
S330-PMC3608974	PMC3608974	2/2013	S330-PMC3608974	['a Neurogenic HYPOTHESIS was formulated to explain HOW neurotoxins produced by Chlorine MAY act on the infant’s immature Central Nervous System with an implication of the Brain’s barrier and Cerebral Spinal Fluid being INVOLVED.']	[('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 50), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0001822', 'kidney development', 2, 'neurogenic'), ('CHEBI_3638', 'chloroquine', 78, 'chlorine'), ('UBERON_0001017', 'central nervous system', 120, 'central nervous system'), ('UBERON_0000955', 'brain', 170, 'brain'), ('UBERON_0001359', 'cerebrospinal fluid', 190, 'cerebral spinal fluid')]	0	[' neurotoxins chlorine infant’s immature central nervous system brain’s cerebral spinal fluid involved.']
S148-PMC3669365	PMC3669365	5/2013	S148-PMC3669365	['as Hmgcs2 is a target Gene of Pparα and a key enzyme in Ketogenesis[28],[29],[30], we CONSIDER that the fetuses of dr Mice were under fasting conditions that produced Ketogenic responses NOT ONLY in the Liver BUT ALSO in the Brain.10.1371/journal.pone.0064263.g005\n\ncaption (fig): figure 5\nMetabolic state in fetal stage (Gestation day 17).']	[('INCOMPLETE_EVIDENCE', 86), ('ANOMALY_CURIOUS_FINDING', 187), ('ANOMALY_CURIOUS_FINDING', 209)]	3	[('PR_000008466', 'hepatitis B virus X-interacting protein', 3, 'Hmgcs2'), ('SO_0000704', 'gene', 22, 'gene'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 30, 'PPARα'), ('GO_0001822', 'kidney development', 56, 'ketogenesis'), ('NCBITaxon_10088', 'Mus <genus>', 118, 'mice'), ('CHEBI_75715', 'dUMP 3*-end residue', 167, 'ketogenic'), ('GO_0000241', 'diakinesis', 167, 'ketogenic'), ('UBERON_0002107', 'liver', 203, 'liver'), ('UBERON_0000955', 'brain', 225, 'brain'), ('GO_0008152', 'metabolic process', 290, 'Metabolic'), ('GO_0007565', 'female pregnancy', 322, 'gestation')]	0	['hmgcs2 gene pparα enzyme [28],[29],[30], fetuses dr mice fasting conditions ketogenic responses liver brain.10.1371/journal.pone.0064263.g005\n\ncaption (fig): figure 5\nmetabolic fetal (gestation day 17).']
S191-PMC3669365	PMC3669365	5/2013	S191-PMC3669365	['the enhancement of Ketogenesis was observed in the fetal dr Mice NOT ONLY in the Liver BUT ALSO in the Brain.']	[('ANOMALY_CURIOUS_FINDING', 65), ('ANOMALY_CURIOUS_FINDING', 87)]	2	[('GO_0001822', 'kidney development', 19, 'ketogenesis'), ('NCBITaxon_10088', 'Mus <genus>', 60, 'mice'), ('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0000955', 'brain', 103, 'brain')]	0	[' fetal dr mice liver brain.']
S19-PMC4231349	PMC4231349	10/2013	S19-PMC4231349	['studies on Adult Humans and rodents HAVE SHOWN that sparse Carbohydrate and Glucose availability initiates a process of Ketogenesis that produces Ketones, which all Organs – including the Brain – can use for energy [6,7].']	[('INCOMPLETE_EVIDENCE', 36)]	1	[('UBERON_0007023', 'adult organism', 11, 'adult'), ('NCBITaxon_9606', 'Homo sapiens', 17, 'humans'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 59, 'carbohydrate'), ('CHEBI_17234', 'glucose', 76, 'glucose'), ('GO_0001822', 'kidney development', 120, 'ketogenesis'), ('CHEBI_17087', 'ketone', 146, 'ketones'), ('UBERON_0000062', 'organ', 165, 'organs'), ('UBERON_0000955', 'brain', 188, 'brain')]	0	['studies adult humans rodents carbohydrate glucose availability initiates process  ketones, organs brain energy [6,7].']
S209-PMC4672086	PMC4672086	12/2015	S209-PMC4672086	['Rodent Brain Development HAS BEEN CORRELATED to the Brain growth spurt, that extends from the Human second trimester to first 2 years of Postnatal Life, corresponding to the CRITICAL and vulnerable time involving Neurogenic and Gliogenic events (dobbing,1968; mendez and adair,1999; patro et al.,2015).']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 174)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007420', 'brain development', 7, 'brain development'), ('UBERON_0000955', 'brain', 7, 'brain'), ('UBERON_0000955', 'brain', 52, 'brain'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('GO_0007567', 'parturition', 137, 'postnatal'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0001822', 'kidney development', 213, 'neurogenic'), ('GO_0042062', 'long-term strengthening of neuromuscular junction', 228, 'gliogenic')]	0	['rodent brain brain spurt, human trimester 2 postnatal life,  gliogenic events (dobbing,1968; mendez adair,1999; patro et al.,2015).']
S61-PMC3458940	PMC3458940	9/2012	S61-PMC3458940	['for this purpose, we selected Bmp7, Foxa1, Pax2, and Wnt7B, which HAVE BEEN IMPLICATED in Kidney Development, Water Transport, and Defense/protection mechanism against injury[15],[20],[21],[22],[23].']	[('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('PR_000000168', 'BMP7', 30, 'Bmp7'), ('PR_000007606', 'forkhead box protein B2', 36, 'Foxa1'), ('PR_000012318', 'paired box protein Pax-6', 43, 'Pax2'), ('PR_000017453', 'protein Wnt-9b', 53, 'Wnt7b'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('CHEBI_15377', 'water', 110, 'water'), ('GO_0006833', 'water transport', 110, 'water transport'), ('GO_0006952', 'defense response', 131, 'defense')]	0	['purpose, selected bmp7, foxa1, pax2, wnt7b, water transport, defense/protection injury[15],[20],[21],[22],[23].']
S19-PMC4703052	PMC4703052	1/2016	S19-PMC4703052	['our FOCUS is on Humans, and we consider the relative costs and effectiveness of each subsystem of Defense, and PROPOSE that the balance of investment in innate versus Acquired Immunity will be shaped by three ecological FACTORS during sensitive periods of Immune Development: (i) the availability of nutritional resources, (ii) the intensity of pathogen exposure and (iii) signals of extrinsic mortality risk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 220)]	3	[('NCBITaxon_9606', 'Homo sapiens', 16, 'humans'), ('GO_0006952', 'defense response', 98, 'defense'), ('GO_0019624', 'atrazine catabolic process to isopropylamine', 167, 'acquired immunity'), ('GO_0001822', 'kidney development', 256, 'immune development'), ('UBERON_0002405', 'immune system', 256, 'immune')]	0	['humans, relative costs subsystem defense, balance innate acquired immunity three ecological sensitive periods : (i) availability nutritional resources, (ii) intensity pathogen exposure (iii) signals extrinsic mortality risk.']
S104-PMC4730270	PMC4730270	12/2015	S104-PMC4730270	['we studied the Prenatal Dexamethasone MODEL in Rats, where maternal treatment with Dexamethasone leads to impaired Nephrogenesis and hypertension in the offspring, and FOUND increased Histone Deacetylase1 in the Kidneys accompanied by increased Angiotensin Ii At1 Receptor and the Thiazide sensitive transporter Ncc Expression.']	[('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 168)]	2	[('GO_0007565', 'female pregnancy', 15, 'prenatal'), ('CHEBI_41879', 'dexamethasone', 24, 'dexamethasone'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('CHEBI_41879', 'dexamethasone', 83, 'dexamethasone'), ('GO_0001822', 'kidney development', 115, 'nephrogenesis'), ('CHEBI_15358', 'histone', 184, 'histone'), ('PR_000008440', 'heart- and neural crest derivatives-expressed protein 2', 184, 'histone deacetylase1'), ('UBERON_0002113', 'kidney', 212, 'kidneys'), ('PR_000001183', 'alpha-1A adrenergic receptor', 245, 'angiotensin II AT1 receptor'), ('CHEBI_50264', 'thiazide', 281, 'thiazide'), ('PR_000009336', 'killer cell immunoglobulin-like receptor 2DS5', 312, 'NCC'), ('GO_0010467', 'gene expression', 316, 'expression')]	0	['prenatal dexamethasone rats, maternal treatment dexamethasone  hypertension offspring, histone deacetylase1 kidneys angiotensin ii at1 receptor thiazide sensitive transporter ncc expression.']
S106-PMC4730270	PMC4730270	12/2015	S106-PMC4730270	['in follow-up studies with the Dexamethasone MODEL we again FOUND increases in Renal Histone deacetylases (hdacs) and decreased Expression of Genes IMPORTANT for Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 147)]	3	[('CHEBI_41879', 'dexamethasone', 30, 'dexamethasone'), ('UBERON_0002113', 'kidney', 78, 'renal'), ('CHEBI_15358', 'histone', 84, 'histone'), ('PR_000043452', 'core histone', 84, 'histone'), ('GO_0010467', 'gene expression', 127, 'expression'), ('SO_0000704', 'gene', 141, 'genes'), ('GO_0001822', 'kidney development', 161, 'nephrogenesis')]	0	['follow-up dexamethasone renal histone deacetylases (hdacs) decreased expression genes .']
S144-PMC4377888	PMC4377888	3/2015	S144-PMC4377888	['in addition, factors INVOLVED in the Ureteric branching and the Epithelisation of the Metanephric Mesenchyme including growth factors and their receptors, degrading enzyme, proto-oncogenes, transcription factors, suppressor Genes Extracellular Matrix, Teratogens and fetal/maternal environment are all INVOLVED in the Regulation Of Kidney Development and CAN impinge on Nephron endowment [61,99].']	[('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 355)]	3	[('UBERON_0000056', 'ureter', 37, 'ureteric'), ('UBERON_0000400', 'jejunal epithelium', 64, 'epithelisation'), ('UBERON_0003220', 'metanephric mesenchyme', 86, 'metanephric mesenchyme'), ('SO_0000704', 'gene', 224, 'genes'), ('GO_0031012', 'extracellular matrix', 230, 'extracellular matrix'), ('CHEBI_50114', 'estrogen', 252, 'teratogens'), ('GO_0007565', 'female pregnancy', 318, 'regulation of'), ('GO_0001822', 'kidney development', 332, 'kidney development'), ('UBERON_0002113', 'kidney', 332, 'kidney'), ('UBERON_0001285', 'nephron', 370, 'nephron')]	0	['addition, ureteric branching epithelisation metanephric mesenchyme receptors, degrading enzyme, proto-oncogenes, transcription factors, suppressor genes extracellular matrix, teratogens fetal/maternal environment  nephron endowment [61,99].']
S33-PMC3749995	PMC3749995	8/2013	S33-PMC3749995	['we used a combination of in vitro and in vivo approaches (using multiple cohorts) to examine the EFFECT of high Extracellular Salt on Kidney Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 97)]	1	[('GO_0005576', 'extracellular region', 112, 'extracellular'), ('CHEBI_24866', 'salt', 126, 'salt'), ('GO_0001822', 'kidney development', 134, 'kidney development'), ('UBERON_0002113', 'kidney', 134, 'kidney')]	0	['combination vivo (using cohorts) extracellular salt  function.']
S128-PMC3749995	PMC3749995	8/2013	S128-PMC3749995	['HOWEVER, the extent to which hypernatraemia in ecf MAY IMPACT Kidney Development in vivo is NOT KNOWN and was THEREFORE tested in our nutritional MODEL.10.1371/journal.pone.0072682.g001\n\ncaption (fig): figure 1\nincreased Extracellular Salt bluntsin vitrokidney but not Lung Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 55), ('FULL_UNKNOWN', 92), ('PROBABLE_UNDERSTANDING', 110), ('INCOMPLETE_EVIDENCE', 146)]	6	[('GO_0001822', 'kidney development', 62, 'kidney development'), ('UBERON_0002113', 'kidney', 62, 'kidney'), ('GO_0005576', 'extracellular region', 221, 'extracellular'), ('CHEBI_24866', 'salt', 235, 'salt'), ('GO_0030324', 'lung development', 269, 'lung development'), ('UBERON_0002048', 'lung', 269, 'lung')]	0	['however, hypernatraemia ecf  vivo nutritional model.10.1371/journal.pone.0072682.g001\n\ncaption (fig): figure 1\nincreased extracellular salt bluntsin vitrokidney lung development.']
S2-PMC3156327	PMC3156327	4/2011	S2-PMC3156327	['PRELIMINARY STUDIES now SUGGEST that these early EFFECTS on Immune Development MAY BE MEDIATED epigenetically through a variety of processes that collectively modify Gene Expression and allergic susceptibility and that these EFFECTS are POTENTIALLY heritable across generations.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 225), ('INCOMPLETE_EVIDENCE', 237)]	7	[('GO_0001822', 'kidney development', 60, 'immune development'), ('UBERON_0002405', 'immune system', 60, 'immune'), ('GO_0010467', 'gene expression', 166, 'gene expression'), ('SO_0000704', 'gene', 166, 'gene')]	0	['preliminary  epigenetically processes collectively gene expression allergic heritable generations.']
S133-PMC3192058	PMC3192058	10/2011	S133-PMC3192058	['all these results INDICATED the damage caused by Utero-Placental insufficiency was DIFFICULT to reverse, supposing it MAY has RELATIONSHIP with Nutrient substance deficiency for Islet Development, Intrauterine environmental failure, increased Hypothalamic-Pituitary-Adrenal (hpa) axis activity and Gene defect[29],[30].']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('UBERON_0000995', 'uterus', 49, 'utero'), ('UBERON_0001987', 'placenta', 55, 'placental'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CL_0000214', 'synovial cell', 178, 'islet'), ('GO_0001822', 'kidney development', 178, 'islet development'), ('UBERON_0002533', 'post-anal tail bud', 178, 'islet'), ('UBERON_0022293', 'reproductive gland secretion', 197, 'intrauterine'), ('UBERON_0001898', 'hypothalamus', 243, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 256, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 266, 'adrenal'), ('SO_0000704', 'gene', 298, 'gene')]	0	['results utero-placental reverse, nutrient substance intrauterine environmental failure, hypothalamic-pituitary-adrenal (hpa) activity gene defect[29],[30].']
S65-PMC3202114	PMC3202114	10/2011	S65-PMC3202114	['under these unique conditions, we have FOUND that maternal diabetes negatively Imprints the growth of a Genetically normal (wistar) Beta-Cell mass in a way as the insult is still present later at Adult age as a decreased Beta-Cell population [42,43].NOT ONLY maternal diabetes BUT ALSO Intrauterine undernutrition induced by several means such as protein (iupr) or calorie (iucr) restriction, or alteration in the availability of the Nutrients by Uterine/Placental insufficiency (upi) induced by Uterine Artery ligation, alter early Islet Development and provoke lasting consequences in rodents.']	[('INCOMPLETE_EVIDENCE', 39), ('ANOMALY_CURIOUS_FINDING', 250), ('ANOMALY_CURIOUS_FINDING', 277)]	3	[('GO_0007566', 'embryo implantation', 79, 'imprints'), ('SO_0000704', 'gene', 104, 'genetically'), ('CL_0000349', 'extraembryonic cell', 132, 'beta-cell'), ('UBERON_0000922', 'embryo', 132, 'beta'), ('UBERON_0007023', 'adult organism', 196, 'adult'), ('CL_0000349', 'extraembryonic cell', 221, 'beta-cell'), ('UBERON_0022293', 'reproductive gland secretion', 286, 'intrauterine'), ('CHEBI_33284', 'nutrient', 434, 'nutrients'), ('UBERON_0000995', 'uterus', 447, 'uterine'), ('UBERON_0001987', 'placenta', 455, 'placental'), ('UBERON_0002493', 'uterine artery', 496, 'uterine artery'), ('CL_0000214', 'synovial cell', 533, 'islet'), ('GO_0001822', 'kidney development', 533, 'islet development'), ('UBERON_0002533', 'post-anal tail bud', 533, 'islet')]	0	['conditions, maternal diabetes imprints genetically normal (wistar) beta-cell mass insult adult age decreased beta-cell population [42,43].not maternal diabetes intrauterine undernutrition induced protein (iupr) calorie (iucr) restriction, alteration availability nutrients uterine/placental (upi) induced uterine artery ligation, alter  lasting rodents.']
S51-PMC3227644	PMC3227644	11/2011	S51-PMC3227644	['these altered responses to fasting were ASSOCIATED with changes in mrna Expression of Hepatic Genes involved in Gluconeogenesis and Ketogenesis (figure 3).']	[('SUPERFICIAL_RELATIONSHIP', 40)]	1	[('GO_0010467', 'gene expression', 72, 'expression'), ('UBERON_0002107', 'liver', 86, 'hepatic'), ('SO_0000704', 'gene', 94, 'genes'), ('GO_0006094', 'gluconeogenesis', 112, 'gluconeogenesis'), ('GO_0001822', 'kidney development', 132, 'ketogenesis')]	0	['altered responses fasting changes mrna expression hepatic genes gluconeogenesis  (figure 3).']
S205-PMC3268605	PMC3268605	8/2011	S205-PMC3268605	['HOWEVER, our data DEMONSTRATE a NOVEL POSSIBILITY that long-term amelioration of hypertension by No in Gestation MAY induce epigenetic changes that AFFECT the Postnatal transcription of Ribosomal protein Genes and a reduction of Ribosome structures during a critical period of Nephrogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('FULL_UNKNOWN', 32), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 148)]	6	[('CHEBI_16382', 'iodide', 97, 'NO'), ('GO_0007565', 'female pregnancy', 103, 'gestation'), ('GO_0007567', 'parturition', 159, 'postnatal'), ('GO_0005840', 'ribosome', 186, 'ribosomal'), ('SO_0000704', 'gene', 204, 'genes'), ('GO_0005840', 'ribosome', 229, 'ribosome'), ('GO_0001822', 'kidney development', 277, 'nephrogenesis')]	0	['however, long-term amelioration hypertension gestation epigenetic changes postnatal transcription ribosomal protein genes reduction ribosome structures period .']
S201-PMC3277098	PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]	0	['future sources vitamin d,  genetic immunological changing vitamin status supplementation lifestyle changes.']
S20-PMC3424155	PMC3424155	8/2012	S20-PMC3424155	"['[""""among the ESSENTIAL regulators of Kidney Development are components of the Renin-angiotensin system (ras), Podocin (a CRITICAL component of the Glomerular Slit Diaphragm) and the wilms\' tumor suppressor Gene Wt1[12].""""]']"	[('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 118)]	2	[('GO_0001822', 'kidney development', 34, 'kidney development'), ('UBERON_0002113', 'kidney', 34, 'kidney'), ('PR_000014368', 'RuvB-like 1', 75, 'renin'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 107, 'podocin'), ('UBERON_0001230', 'glomerular capsule', 144, 'glomerular slit'), ('UBERON_0001103', 'diaphragm', 160, 'diaphragm'), ('SO_0000704', 'gene', 203, 'gene'), ('PR_000017450', 'protein Wnt-8a', 208, 'WT1')]	0	"['[""""among ent renin-angiotensin system (ras), podocin (a glomerular slit diaphragm) wilms* tumor suppressor gene wt1[12].""""]']"
S0-PMC3458940	PMC3458940	9/2012	S0-PMC3458940	['Retinoic Acid receptor-dependent, cell-autonomous, endogenous Retinoic Acid signaling and its target Genes in Mouse Collecting Duct Cells\n\nabstract\n\nbackground\nVitamin A is NECESSARY for Kidney Development and HAS also BEEN LINKED to Regulation Of solute and Water Homeostasis and to protection against Kidney stone disease, infection, inflammation, and scarring.']	[('IMPORTANT_CONSIDERATION', 173), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 224)]	3	[('CHEBI_28592', 'ricinoleic acid', 0, 'Retinoic Acid'), ('PR_000014000', 'telomere-associated protein RIF1', 0, 'Retinoic Acid'), ('CHEBI_28592', 'ricinoleic acid', 62, 'Retinoic Acid'), ('SO_0000704', 'gene', 101, 'Genes'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'Mouse'), ('UBERON_0001232', 'collecting duct of renal tubule', 116, 'Collecting Duct'), ('CL_0000125', 'glial cell', 127, 'Duct Cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 160, 'Vitamin A'), ('GO_0001822', 'kidney development', 187, 'kidney development'), ('UBERON_0002113', 'kidney', 187, 'kidney'), ('GO_0065007', 'biological regulation', 234, 'regulation of ...'), ('CHEBI_15377', 'water', 259, 'water'), ('GO_0030104', 'water homeostasis', 259, 'water homeostasis'), ('UBERON_0002113', 'kidney', 303, 'kidney')]	0	['retinoic acid receptor-dependent, cell-autonomous, endogenous retinoic acid signaling genes mouse collecting duct cells\n\nabstract\n\nbackground\nvitamin  solute water homeostasis kidney stone disease, infection, inflammation, scarring.']
S7-PMC3458940	PMC3458940	9/2012	S7-PMC3458940	['NEVERTHELESS, Gene ontology analysis SUGGESTS that these Genes are INVOLVED in Kidney Development, Renal functioning, and Regulation Of tra signaling.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('SO_0000704', 'gene', 14, 'gene'), ('SO_0000704', 'gene', 57, 'genes'), ('GO_0001822', 'kidney development', 79, 'kidney development'), ('UBERON_0002113', 'kidney', 79, 'kidney'), ('UBERON_0002113', 'kidney', 99, 'renal'), ('GO_0065007', 'biological regulation', 122, 'regulation of ...')]	0	['nevertheless, gene ontology genes renal functioning, tra signaling.']
S130-PMC3458940	PMC3458940	9/2012	S130-PMC3458940	['these Genes were reported to be INVOLVED in Regulating the conversion of tral into trol (Dhrs3), Regulating Ub Branching and Kidney Development (Ppbp and Bmp7), maintaining cd cell polarity and integrity by Regulating cell-cell and cell-substrate interactions (tns1 and itga2), Regulating Cellular Responses To Stress and Modulating Tissue Repair (sprr1a, Cpm, Lcn2, and Bmp7), Regulating Water and Solute Transport mechanisms, and Kidney stone Formation (Npr3, Foxa1, clca4, Slc37A1, and Galns).']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('SO_0000704', 'gene', 6, 'genes'), ('GO_0065007', 'biological regulation', 44, 'regulating'), ('PR_000006602', 'dynamin-1-like protein', 89, 'Dhrs3'), ('GO_0065007', 'biological regulation', 97, 'regulating'), ('UBERON_0001828', 'gingiva', 108, 'UB'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 111, 'branching'), ('GO_0001822', 'kidney development', 125, 'kidney development'), ('UBERON_0002113', 'kidney', 125, 'kidney'), ('PR_000013350', 'pregnancy-specific beta-1-glycoprotein 2', 145, 'Ppbp'), ('PR_000000168', 'BMP7', 154, 'Bmp7'), ('GO_0065007', 'biological regulation', 207, 'regulating'), ('GO_0065007', 'biological regulation', 278, 'regulating'), ('GO_0035903', 'cellular response to immobilization stress', 289, 'cellular responses to stress'), ('GO_0065007', 'biological regulation', 322, 'modulating'), ('GO_0031649', 'heat generation', 333, 'tissue repair'), ('UBERON_0000479', 'tissue', 333, 'tissue'), ('PR_000004968', 'calretinin', 356, 'Cpm'), ('PR_000009880', 'Lon protease, mitochondrial', 361, 'Lcn2'), ('PR_000000168', 'BMP7', 371, 'Bmp7'), ('GO_0065007', 'biological regulation', 378, 'regulating'), ('CHEBI_15377', 'water', 389, 'water'), ('GO_0007605', 'sensory perception of sound', 389, 'water ...'), ('GO_0006814', 'sodium ion transport', 399, 'solute transport'), ('GO_0016255', 'attachment of GPI anchor to protein', 432, 'kidney'), ('UBERON_0002113', 'kidney', 432, 'kidney'), ('GO_0009057', 'macromolecule catabolic process', 445, 'formation'), ('PR_000011509', 'nuclear pore complex protein Nup155', 456, 'Npr3'), ('PR_000007606', 'forkhead box protein B2', 462, 'Foxa1'), ('PR_000015124', 'zinc transporter ZIP10', 476, 'Slc37a1'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 489, 'Galns')]	0	['genes conversion tral trol (dhrs3), ub branching  (ppbp bmp7), maintaining cd cell polarity integrity cell-cell cell-substrate (tns1 itga2), cellular responses tissue repair (sprr1a, cpm, lcn2, bmp7), water solute transport mechanisms, kidney stone formation (npr3, foxa1, clca4, slc37a1, galns).']
S162-PMC3458940	PMC3458940	9/2012	S162-PMC3458940	['for instance, Ppbp COULD BE Regulating Kidney Development[45], inflammation[46], and Defense Against bacterial Infection[47]; sprr1a is another Gene highly dependent on tra/rar signaling in mediating Tissue Repair and Regeneration[48]RELEVANT to Kidney injury.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 234)]	2	[('PR_000013350', 'pregnancy-specific beta-1-glycoprotein 2', 14, 'Ppbp'), ('GO_0065007', 'biological regulation', 28, 'regulating'), ('GO_0001822', 'kidney development', 39, 'kidney development'), ('UBERON_0002113', 'kidney', 39, 'kidney'), ('GO_0050888', 'determination of stimulus location', 85, 'defense against ... infection'), ('SO_0000704', 'gene', 144, 'gene'), ('GO_0072679', 'thymocyte migration', 200, 'tissue repair ... regeneration'), ('UBERON_0000479', 'tissue', 200, 'tissue'), ('UBERON_0002113', 'kidney', 246, 'kidney')]	0	['instance, ppbp [45], inflammation[46], defense bacterial infection[47]; sprr1a gene tra/rar signaling tissue repair regeneration[48]relevant kidney injury.']
S171-PMC3458940	PMC3458940	9/2012	S171-PMC3458940	['we PROPOSE that endogenous tra/rars MAY play CRUCIAL ROLES in Kidney Development and in maintaining normal function of Cd Cells and the Kidney, AT LEAST in part, by Regulating these tra/rar target Genes.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 144)]	5	[('GO_0001822', 'kidney development', 62, 'kidney development'), ('UBERON_0002113', 'kidney', 62, 'kidney'), ('CL_0000051', 'common lymphoid progenitor', 119, 'CD cells'), ('UBERON_0002113', 'kidney', 136, 'kidney'), ('GO_0065007', 'biological regulation', 165, 'regulating'), ('SO_0000704', 'gene', 197, 'genes')]	0	['endogenous tra/rars play  maintaining cd cells kidney, part, tra/rar genes.']
S23-PMC3488908	PMC3488908	4/2010	S23-PMC3488908	['there is now GOOD EVIDENCE that a NUMBER OF maternal environmental exposures in Pregnancy have the capacity to modify fetal Immune Development and Perinatal Immune function.1the EMERGING field of epigenetics also provides a NEW PERSPECTIVE on the mechanisms by which environmental changes CAN be inducing changes in Gene Expression and disease susceptibility in subsequent Life.4epigenetic Regulation refers to the Control Of Gene Expression by changes in Dna and Histone Methylation, Histone Acetylation, and Chromatin structure, as reviewed in detail elsewhere.5these induce conformational changes, which activate or silence Genes by determining the degree of Dna Compaction and accessibility for Gene transcription.']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 178), ('FULL_UNKNOWN', 224), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 289)]	6	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0001822', 'kidney development', 124, 'immune development'), ('UBERON_0002405', 'immune system', 124, 'immune'), ('GO_0036268', 'swimming', 147, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 147, 'perinatal'), ('UBERON_0002405', 'immune system', 157, 'immune'), ('GO_0010467', 'gene expression', 316, 'gene expression'), ('SO_0000704', 'gene', 316, 'gene'), ('UBERON_0000104', 'life cycle', 373, 'life'), ('GO_0065007', 'biological regulation', 390, 'regulation'), ('GO_0010468', 'regulation of gene expression', 415, 'control of gene expression'), ('SO_0000704', 'gene', 426, 'gene'), ('GO_0006306', 'DNA methylation', 456, 'DNA ... histone methylation'), ('CHEBI_15358', 'histone', 464, 'histone'), ('PR_000043452', 'core histone', 464, 'histone'), ('CHEBI_15358', 'histone', 485, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 485, 'histone acetylation'), ('PR_000043452', 'core histone', 485, 'histone'), ('GO_0000785', 'chromatin', 510, 'chromatin'), ('SO_0000704', 'gene', 627, 'genes'), ('GO_0006260', 'DNA replication', 662, 'DNA compaction'), ('SO_0000704', 'gene', 699, 'gene')]	0	['maternal environmental exposures pregnancy capacity fetal  perinatal immune function.1the epigenetics mechanisms environmental changes inducing changes gene expression disease life.4epigenetic refers gene expression changes dna histone methylation, histone acetylation, chromatin structure, detail elsewhere.5these conformational changes, activate silence genes degree dna compaction accessibility gene transcription.']
S26-PMC3488908	PMC3488908	4/2010	S26-PMC3488908	['NOTABLY, an Animal MODEL using maternal supplementation with dietary Methyl Donors (Folate) in Pregnancy was shown to induce patterns of Gene Methylation (silencing), which promoted an allergic phenotype in the offspring, and that this EFFECT was heritable to the next generation.10the SIGNIFICANCE of this is NOT CLEAR in Humans; HOWEVER, one RECENT STUDY has REPORTED that Folate supplements in Pregnancy are ASSOCIATED with increased childhood wheezing11and another epidemiological STUDY REPORTED increasing incidence of asthma in 3.5-year-old children of mothers taking Folic Acid supplements during Pregnancy.12ALTHOUGH this clearly WARRANTS FURTHER INVESTIGATION, these OBSERVATIONS HIGHLIGHT the IMPORTANCE of CONSIDERING Antenatal events in subsequent PATTERNS of Immune Development and disease susceptibility.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 236), ('IMPORTANT_CONSIDERATION', 286), ('FULL_UNKNOWN', 310), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 331), ('INCOMPLETE_EVIDENCE', 344), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 491), ('ANOMALY_CURIOUS_FINDING', 614), ('FUTURE_WORK', 638), ('INCOMPLETE_EVIDENCE', 676), ('INCOMPLETE_EVIDENCE', 689), ('IMPORTANT_CONSIDERATION', 703), ('FUTURE_WORK', 717), ('IMPORTANT_CONSIDERATION', 717), ('SUPERFICIAL_RELATIONSHIP', 760)]	19	[('NCBITaxon_33208', 'Metazoa', 12, 'animal'), ('CHEBI_6842', 'methoxychlor', 69, 'methyl donors'), ('CHEBI_30863', '5-azaorotic acid', 84, 'folate'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('GO_0010467', 'gene expression', 137, 'gene methylation'), ('SO_0000704', 'gene', 137, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 323, 'humans'), ('CHEBI_30863', '5-azaorotic acid', 375, 'folate'), ('GO_0007565', 'female pregnancy', 397, 'pregnancy'), ('CHEBI_30751', 'formic acid', 574, 'folic acid'), ('GO_0007565', 'female pregnancy', 604, 'pregnancy'), ('GO_0007567', 'parturition', 729, 'antenatal'), ('GO_0001822', 'kidney development', 772, 'immune development'), ('UBERON_0002405', 'immune system', 772, 'immune')]	0	['notably, animal using maternal supplementation dietary methyl donors (folate) pregnancy gene methylation (silencing), allergic phenotype offspring, heritable generation.10the humans; however, folate supplements pregnancy childhood wheezing11and epidemiological asthma 3.5-year-old children mothers folic acid supplements pregnancy.12although investigation, antenatal events  disease susceptibility.']
S138-PMC3773449	PMC3773449	8/2013	S138-PMC3773449	['the Expression of specific Genes INVOLVED in Nephrogenesis is altered (Pax2, Gdnf) [113,115].']	[('SUPERFICIAL_RELATIONSHIP', 33)]	1	[('GO_0010467', 'gene expression', 4, 'expression'), ('SO_0000704', 'gene', 27, 'genes'), ('GO_0001822', 'kidney development', 45, 'nephrogenesis'), ('PR_000012318', 'paired box protein Pax-6', 71, 'Pax2'), ('PR_000007939', 'glial fibrillary acidic protein', 77, 'GDNF')]	0	['expression genes  altered (pax2, gdnf) [113,115].']
S172-PMC3773449	PMC3773449	8/2013	S172-PMC3773449	['environment MAY alter Nephrogenesis through epigenetic pathway, and Genetic background MAY make the Kidney less or more sensitive to environmental FACTORS.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 147)]	3	[('GO_0001822', 'kidney development', 22, 'nephrogenesis'), ('SO_0000704', 'gene', 68, 'genetic'), ('UBERON_0002113', 'kidney', 100, 'kidney')]	0	['environment alter  epigenetic pathway, genetic background kidney sensitive environmental factors.']
S132-PMC4090150	PMC4090150	7/2014	S132-PMC4090150	['these results INDICATE that the differences in the amount of maternal Fa during Gestation CAN Modulate Expression of neural Genes in the offsprings’ Cerebral Hemispheres.10.1371/journal.pone.0101674.t001\n\ncaption (table-wrap): table 1\nNeural Genes altered ≥2 fold in the Cerebral Hemisphere of male pups from mothers having Fa supplementation during Gestation at 4 mg/kg in comparison to mothers at 0.4 mg/kg diet.accessionsymbolfold changedirection of changepathwayref|nm_008313htr4−3.70↓Dopa-seretoninref|nm_013561htr3a−3.67↓Dopa-seretoninref|nm_019823cyp2d22−3.04↓Dopa-seretoninref|nm_015743nr4a3−2.60↓Dopa-seretoninref|nm_001038845p2rx7−3.96↓Gaba-glutamateref|nm_009732avp−3.77↓Gaba-glutamateref|nm_007699chrm4−3.12↓neuro-transmitterref|nm_009170shh−3.49↓Neurogenesisref|nm_009115s100b−2.99↓Neurogenesisref|nm_010291gjb5−2.50↓gap junctionsref|nm_008123gja8−2.07↓gap junctionsref|nm_019827gsk3b3.27↑Dopa-seretoninref|nm_009414tph12.48↑Dopa-seretoninref|nm_173391tph22.14↑Dopa-seretoninref|nm_013761srr2.35↑Gaba-glutamateref|nm_182959slc17a82.30↑Gaba-glutamateref|nm_008068gabra62.15↑Gaba-glutamateref|nm_010623kif172.43↑Synaptic plasticityref|nm_008689nfkb12.25↑Synaptic plasticityref|nm_001042528cacna1b2.42↑Neuronal-Ion channelsref|nm_145983kcna52.11↑Neuronal-Ion channelsref|nm_008426kcnj32.09↑Neuronal-Ion channelsref|nm_018732scn3a2.07↑Neuronal-Ion channelsref|nm_177781trpa12.00↑Neuronal-Ion channelsref|nm_021382tacr32.20↑neurotransmitterref|nm_009216sstr12.17↑neurotransmitterref|nm_008312htr2c2.12↑neurotransmitterref|nm_001001496gja62.07↑gap junctionsref|nm_172989lpar12.03↑gap junctionsref|nm_008737nrp12.30↑Neurogenesis\n↑\u200a=\u200aup regulated.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 90)]	2	[('CHEBI_30751', 'formic acid', 70, 'FA'), ('GO_0007565', 'female pregnancy', 80, 'gestation'), ('GO_0065007', 'biological regulation', 94, 'modulate'), ('GO_0010467', 'gene expression', 103, 'expression'), ('SO_0000704', 'gene', 124, 'genes'), ('UBERON_0014644', 'cerebrocerebellum', 149, 'cerebral hemispheres'), ('CL_0002319', 'neural cell', 235, 'Neural'), ('SO_0000704', 'gene', 242, 'genes'), ('UBERON_0014644', 'cerebrocerebellum', 271, 'cerebral hemisphere'), ('CHEBI_30751', 'formic acid', 324, 'FA'), ('GO_0007565', 'female pregnancy', 350, 'gestation'), ('CHEBI_81999', 'Dehydrogriseofulvin', 489, 'Dopa'), ('CHEBI_81999', 'Dehydrogriseofulvin', 527, 'Dopa'), ('CHEBI_81999', 'Dehydrogriseofulvin', 567, 'Dopa'), ('CHEBI_81999', 'Dehydrogriseofulvin', 605, 'Dopa'), ('CHEBI_16865', 'gamma-aminobutyric acid', 646, 'GABA'), ('CHEBI_16865', 'gamma-aminobutyric acid', 682, 'GABA'), ('GO_0007285', 'primary spermatocyte growth', 759, 'Neurogenesisref'), ('GO_0007285', 'primary spermatocyte growth', 795, 'Neurogenesisref'), ('CHEBI_81999', 'Dehydrogriseofulvin', 902, 'Dopa'), ('CHEBI_81999', 'Dehydrogriseofulvin', 938, 'Dopa'), ('CHEBI_81999', 'Dehydrogriseofulvin', 974, 'Dopa'), ('CHEBI_16865', 'gamma-aminobutyric acid', 1009, 'GABA'), ('CHEBI_16865', 'gamma-aminobutyric acid', 1048, 'GABA'), ('CHEBI_16865', 'gamma-aminobutyric acid', 1086, 'GABA'), ('GO_0045202', 'synapse', 1123, 'Synaptic'), ('GO_0045202', 'synapse', 1165, 'Synaptic'), ('CL_0000540', 'neuron', 1212, 'Neuronal'), ('CHEBI_24870', 'ion', 1221, 'Ion'), ('CL_0000540', 'neuron', 1256, 'Neuronal'), ('CHEBI_24870', 'ion', 1265, 'Ion'), ('CL_0000540', 'neuron', 1300, 'Neuronal'), ('CHEBI_24870', 'ion', 1309, 'Ion'), ('CL_0000540', 'neuron', 1344, 'Neuronal'), ('CHEBI_24870', 'ion', 1353, 'Ion'), ('CL_0000540', 'neuron', 1388, 'Neuronal'), ('CHEBI_24870', 'ion', 1397, 'Ion'), ('GO_0001822', 'kidney development', 1622, 'Neurogenesis')]	0	['results maternal fa gestation expression neural genes offsprings’ cerebral hemispheres.10.1371/journal.pone.0101674.t001\n\ncaption (table-wrap): table 1\nneural genes altered ≥2 fold cerebral hemisphere male pups mothers fa supplementation gestation 4 mg/kg mothers 0.4 mg/kg diet.accessionsymbolfold changedirection changepathwayref|nm_008313htr4−3.70↓dopa-seretoninref|nm_013561htr3a−3.67↓dopa-seretoninref|nm_019823cyp2d22−3.04↓dopa-seretoninref|nm_015743nr4a3−2.60↓dopa-seretoninref|nm_001038845p2rx7−3.96↓gaba-glutamateref|nm_009732avp−3.77↓gaba-glutamateref|nm_007699chrm4−3.12↓neuro-transmitterref|nm_009170shh−3.49↓neurogenesisref|nm_009115s100b−2.99↓neurogenesisref|nm_010291gjb5−2.50↓gap junctionsref|nm_008123gja8−2.07↓gap junctionsref|nm_019827gsk3b3.27↑dopa-seretoninref|nm_009414tph12.48↑dopa-seretoninref|nm_173391tph22.14↑dopa-seretoninref|nm_013761srr2.35↑gaba-glutamateref|nm_182959slc17a82.30↑gaba-glutamateref|nm_008068gabra62.15↑gaba-glutamateref|nm_010623kif172.43↑synaptic plasticityref|nm_008689nfkb12.25↑synaptic plasticityref|nm_001042528cacna1b2.42↑neuronal-ion channelsref|nm_145983kcna52.11↑neuronal-ion channelsref|nm_008426kcnj32.09↑neuronal-ion channelsref|nm_018732scn3a2.07↑neuronal-ion channelsref|nm_177781trpa12.00↑neuronal-ion channelsref|nm_021382tacr32.20↑neurotransmitterref|nm_009216sstr12.17↑neurotransmitterref|nm_008312htr2c2.12↑neurotransmitterref|nm_001001496gja62.07↑gap junctionsref|nm_172989lpar12.03↑gap junctionsref|nm_008737nrp12.30↑\n↑\u200a=\u200aup regulated.']
S224-PMC4161944	PMC4161944	9/2014	S224-PMC4161944	['optimization of existing vaccine scheduling MAY SEEM TO BE low hanging fruit, but will REQUIRE thorough analysis of local Immune Development with CONSIDERATION of both Genetic and environmental factors.']	[('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 48), ('FUTURE_WORK', 87), ('FUTURE_WORK', 146)]	4	[('GO_0001822', 'kidney development', 122, 'immune development'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('SO_0000704', 'gene', 168, 'genetic')]	0	['optimization vaccine scheduling hanging fruit, thorough local  genetic environmental factors.']
S20-PMC4377888	PMC4377888	3/2015	S20-PMC4377888	['the developing Kidney is particularly susceptible to the EFFECTS of a suboptimal maternal diet; changes in Expression of Genes and proteins important for Kidney Development, are LIKELY to UNDERLIE the developmental programming of Kidney structure and physiology.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('PROBABLE_UNDERSTANDING', 178), ('SUPERFICIAL_RELATIONSHIP', 188)]	3	[('UBERON_0002113', 'kidney', 15, 'kidney'), ('GO_0010467', 'gene expression', 107, 'expression'), ('SO_0000704', 'gene', 121, 'genes'), ('GO_0001822', 'kidney development', 154, 'kidney development'), ('UBERON_0002113', 'kidney', 154, 'kidney'), ('GO_0016255', 'attachment of GPI anchor to protein', 230, 'kidney'), ('UBERON_0002113', 'kidney', 230, 'kidney')]	0	['kidney maternal diet; changes expression genes proteins developmental programming kidney structure physiology.']
S161-PMC4377888	PMC4377888	3/2015	S161-PMC4377888	['abdel-hakkem and colleagues (2008) induced global caloric restriction in sprague-dawley Rats, and analyzed 10 CRITICAL Genes involved in Branching Morphogenesis and Nephrogenesis at e20 [110].']	[('IMPORTANT_CONSIDERATION', 110)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 88, 'rats'), ('SO_0000704', 'gene', 119, 'genes'), ('GO_0001763', 'morphogenesis of a branching structure', 137, 'branching morphogenesis'), ('GO_0001822', 'kidney development', 165, 'nephrogenesis')]	0	['abdel-hakkem colleagues (2008) induced caloric sprague-dawley rats, 10 genes branching morphogenesis  e20 [110].']
S215-PMC4377888	PMC4377888	3/2015	S215-PMC4377888	['offspring of Rats whose mothers were Fed protein restricted diets in Pregnancy and Lactation demonstrate global changes to the methylation status of whole Organs, and IMPORTANT Gene pathways that play a MAJOR ROLE in Kidney Development and Adult function [130,131,132].']	[('IMPORTANT_CONSIDERATION', 167), ('IMPORTANT_CONSIDERATION', 203), ('SUPERFICIAL_RELATIONSHIP', 209)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rats'), ('GO_0007631', 'feeding behavior', 37, 'fed'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007595', 'lactation', 83, 'lactation'), ('UBERON_0000062', 'organ', 155, 'organs'), ('SO_0000704', 'gene', 177, 'gene'), ('GO_0001822', 'kidney development', 217, 'kidney development'), ('UBERON_0002113', 'kidney', 217, 'kidney'), ('UBERON_0007023', 'adult organism', 240, 'adult')]	0	['offspring rats whose mothers fed protein diets pregnancy lactation changes methylation status whole organs, gene play  adult [130,131,132].']
S219-PMC4377888	PMC4377888	3/2015	S219-PMC4377888	['2010, SUGGEST that a number OF Genes UNDERLYING Ureteric Bud formation (including elements of the Renin angiotensin system) are Controlled by Histone Acetylation; certainly hdac inhibitors have a negative IMPACT on Kidney Development.']	[('INCOMPLETE_EVIDENCE', 6), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 205)]	4	[('SO_0000704', 'gene', 31, 'genes'), ('UBERON_0000084', 'ureteric bud', 48, 'ureteric bud'), ('PR_000014368', 'RuvB-like 1', 98, 'renin'), ('GO_0065007', 'biological regulation', 128, 'controlled'), ('CHEBI_15358', 'histone', 142, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 142, 'histone acetylation'), ('PR_000043452', 'core histone', 142, 'histone'), ('GO_0001822', 'kidney development', 215, 'kidney development'), ('UBERON_0002113', 'kidney', 215, 'kidney')]	0	['2010, genes ureteric bud formation (including elements renin angiotensin system) histone acetylation; hdac inhibitors .']
S70-PMC4730270	PMC4730270	12/2015	S70-PMC4730270	['THEREFORE, EVEN THOUGH changes in the Intrarenal Renin-angiotensin system during developmental programming are WELL RECOGNIZED [57], we have NOT included studies where blocking the renin-angiotensin system after the period of Nephrogenesis prevented Genetic hypertension in spontaneously hypertensive Rats (shr) [58,59,60] or acquired hypertension after maternal protein or caloric restriction [61,62,63,64].']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 16), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 116), ('ANOMALY_CURIOUS_FINDING', 141)]	6	[('UBERON_0006687', 'median sacral vein', 38, 'intrarenal'), ('PR_000014368', 'RuvB-like 1', 49, 'renin'), ('GO_0001822', 'kidney development', 226, 'nephrogenesis'), ('SO_0000704', 'gene', 250, 'genetic'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 301, 'rats')]	0	['therefore, changes intrarenal renin-angiotensin system developmental programming [57], blocking renin-angiotensin system period  genetic hypertension spontaneously hypertensive rats (shr) [58,59,60] acquired hypertension maternal protein caloric [61,62,63,64].']
S80-PMC4730270	PMC4730270	12/2015	S80-PMC4730270	['differentially Expressed Genes (degs) are already observed at two and seven days of age (mid-Nephrogenesis in the Rat) [42,66,69] and two weeks of age [46,66,67,68,69,70], PROBABLY before development of the hypertensive phenotype.']	[('PROBABLE_UNDERSTANDING', 172)]	1	[('GO_0010467', 'gene expression', 15, 'expressed'), ('SO_0000704', 'gene', 25, 'genes'), ('GO_0001822', 'kidney development', 93, 'nephrogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 114, 'rat')]	0	['differentially expressed genes (degs) seven days age (mid- rat) [42,66,69] weeks age [46,66,67,68,69,70], hypertensive phenotype.']
S82-PMC4730270	PMC4730270	12/2015	S82-PMC4730270	['because reduced Nephron number plays a CRUCIAL ROLE in programmed hypertension [8], we used to analyze a number of Nephrogenesis-related Genes in offspring Kidney at 2 weeks of age in a variety of nutritional programming models [66].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('UBERON_0001285', 'nephron', 16, 'nephron'), ('GO_0001822', 'kidney development', 115, 'nephrogenesis'), ('SO_0000704', 'gene', 137, 'genes'), ('UBERON_0002113', 'kidney', 156, 'kidney')]	0	['nephron plays programmed hypertension [8], -related genes offspring kidney 2 weeks age nutritional programming [66].']
S50-PMC3227644	PMC3227644	11/2011	S50-PMC3227644	['Plasma Glucose concentration was lower (generation f(1856,5.3) 25.6, p<0.0001) and Β-Hydroxybutyrate (βhb) (generation f(1934712,164232) 11.8, p<0.0001) concentration was higher in f2 dams than f0 dams during this test SUGGESTING that there was a transition towards greater Glucose utilisation and increased Glucose sparing by Ketogenesis in f2 dams (figure 3).']	[('INCOMPLETE_EVIDENCE', 219)]	1	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_17234', 'glucose', 7, 'glucose'), ('CHEBI_37054', '3-hydroxybutyrate', 83, 'β-hydroxybutyrate'), ('CHEBI_17234', 'glucose', 274, 'glucose'), ('CHEBI_17234', 'glucose', 308, 'glucose'), ('GO_0001822', 'kidney development', 327, 'ketogenesis')]	0	['plasma glucose concentration (generation f(1856,5.3) 25.6, p<0.0001) β-hydroxybutyrate (βhb) (generation f(1934712,164232) 11.8, p<0.0001) concentration higher f2 dams f0 dams transition glucose utilisation glucose sparing  f2 dams (figure 3).']
S167-PMC3685567	PMC3685567	5/2013	S167-PMC3685567	['this OBSERVATION SUGGESTS that assuming Ketolytic enzymes are available to facilitate Ketone Oxidation [43], then the fetal Mouse utilizes both Glucose and Ketone in early and mid Gestation.']	[('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 17)]	2	[('GO_0001822', 'kidney development', 40, 'ketolytic'), ('CHEBI_17087', 'ketone', 86, 'ketone'), ('GO_0097577', 'sequestering of iron ion', 86, 'ketone oxidation'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mouse'), ('CHEBI_17234', 'glucose', 144, 'glucose'), ('CHEBI_17087', 'ketone', 156, 'ketone'), ('GO_0007565', 'female pregnancy', 180, 'gestation')]	0	[' enzymes ketone oxidation [43], fetal mouse utilizes glucose ketone mid gestation.']
S377-PMC4392553	PMC4392553	3/2015	S377-PMC4392553	['ON THE OTHER HAND, the Hydrophilic Bile Acid, Ursodeoxycholic Acid (Udca), is PROTECTIVE, and its PROTECTIVE EFFECTS HAVE BEEN PROPOSED to be due to its ability to induce the Expression of Cyp3A4, a Bile-Metabolizing enzyme, in Hepatocytes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 98), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127)]	6	[('CHEBI_24757', 'hypochlorous acid', 23, 'hydrophilic'), ('CHEBI_3098', 'bile acid', 35, 'bile acid'), ('UBERON_0001970', 'bile', 35, 'bile'), ('CHEBI_85934', '(2R)-2-hydroxytetradecanoic acid', 46, 'ursodeoxycholic acid'), ('CHEBI_34902', 'Olprinone hydrochloride', 68, 'UDCA'), ('GO_0010467', 'gene expression', 175, 'expression'), ('PR_000006131', 'cytochrome P450 3A43', 189, 'CYP3A4'), ('GO_0001822', 'kidney development', 199, 'bile-metabolizing'), ('UBERON_0001970', 'bile', 199, 'bile'), ('CL_0000182', 'hepatocyte', 228, 'hepatocytes')]	0	['hand, hydrophilic bile acid, ursodeoxycholic acid (udca), protective, ability expression cyp3a4,  enzyme, hepatocytes.']
S79-PMC3271107	PMC3271107	2/2012	S79-PMC3271107	"['[""""in addition, ALTHOUGH Insulin hasn\'t been PREVIOUSLY LINKED to Neurogenesis, STUDIES HAVE SHOWN that Insulin-Like Growth Factor I (Igf-I)-dependent Neurogenesis in Adult Rats did not affect any particular nucleus and occurred diffusely throughout the Hypothalamus, with the EXCEPTION of the Periventricular Zone of the so-called overlapping region (CONSIDERED a Neurogenic niche)[27].""""]']"	[('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 85), ('ANOMALY_CURIOUS_FINDING', 274), ('INCOMPLETE_EVIDENCE', 349)]	7	[('PR_000045358', 'insulin family protein', 22, 'insulin'), ('GO_0022008', 'neurogenesis', 63, 'neurogenesis'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 101, 'insulin-like growth factor I'), ('PR_000008919', 'interferon alpha-6', 131, 'IGF-I'), ('GO_0022008', 'neurogenesis', 148, 'neurogenesis'), ('UBERON_0007023', 'adult organism', 164, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 170, 'rats'), ('UBERON_0001898', 'hypothalamus', 251, 'hypothalamus'), ('UBERON_0003040', 'central gray substance of midbrain', 291, 'periventricular zone'), ('GO_0001822', 'kidney development', 362, 'neurogenic')]	0	"['[""""in addition, insulin hasn*t neurogenesis, insulin-like (igf-i)-dependent neurogenesis adult rats nucleus throughout hypothalamus, periventricular zone region (considerednic niche)[27].""""]']"
S222-PMC4264037	PMC4264037	9/2014	S222-PMC4264037	"['[""""GIVEN Shh\'s ROLE in promoting the Formation Of the Ventral Diencephalon, and the fact that several of the bhlh transcription factors that Govern Hypothalamic Neurogenesis are downstream of Hedgehog Signaling[87], it is tempting to SPECULATE that leptin\'s pro-Neurogenic EFFECTS on the Embryonic Mediobasal Hypothalamus involve Shh in SOME fashion.""""]']"	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 231), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 334)]	5	[('PR_000014841', 'sonic hedgehog protein', 6, 'Shh'), ('GO_0060423', 'foregut regionalization', 34, 'formation of ... diencephalon'), ('UBERON_0000204', 'ventral part of telencephalon', 51, 'ventral diencephalon'), ('GO_0065007', 'biological regulation', 138, 'govern'), ('UBERON_0001898', 'hypothalamus', 145, 'hypothalamic'), ('GO_0022008', 'neurogenesis', 158, 'neurogenesis'), ('GO_0007224', 'smoothened signaling pathway', 189, 'hedgehog signaling'), ('GO_0001822', 'kidney development', 259, 'neurogenic'), ('UBERON_0000922', 'embryo', 285, 'embryonic'), ('UBERON_0013159', 'epithalamus mantle layer', 295, 'mediobasal hypothalamus'), ('PR_000014841', 'sonic hedgehog protein', 327, 'Shh')]	0	"['[""""given shh*s promoting formation ventral diencephalon, bhlh transcription govern hypothalamic neurogenesis hedgehog signaling[87], leptin*s pnic embryonic mediobasal hypothalamus shh fashion.""""]']"
S305-PMC3728489	PMC3728489	7/2013	S305-PMC3728489	['SINCE Iodine WAS NOT discussed in the earlier section on fetal Immune Development, we NOTE that INCREASING EVIDENCE SUGGESTS that the Immune Response is Modulated by Thyroid hormones (de vito et al.,2011).']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 86), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 116)]	5	[('CHEBI_24859', 'iodine atom', 6, 'iodine'), ('GO_0001822', 'kidney development', 63, 'immune development'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('GO_0006955', 'immune response', 134, 'immune response'), ('UBERON_0002405', 'immune system', 134, 'immune'), ('GO_0065007', 'biological regulation', 153, 'modulated'), ('CHEBI_9437', 'temoporfin', 166, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 166, 'thyroid')]	0	['since iodine section fetal immune response thyroid hormones (de vito et al.,2011).']
S16-PMC5679631	PMC5679631	11/2017	S16-PMC5679631	['introduction\nthe Intestinal microbiota plays a DECISIVE ROLE in directing Immune Development early post-Partum and shaping Immune Responses throughout Life [1].']	[('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('UBERON_0000160', 'intestine', 17, 'intestinal'), ('GO_0001822', 'kidney development', 74, 'immune development'), ('UBERON_0002405', 'immune system', 74, 'immune'), ('GO_0007567', 'parturition', 104, 'partum'), ('GO_0006955', 'immune response', 123, 'immune responses'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('UBERON_0000104', 'life cycle', 151, 'life')]	0	['introduction\nthe intestinal microbiota plays directing  post-partum shaping immune responses throughout life [1].']
S14-PMC5716389	PMC5716389	9/2017	S14-PMC5716389	['suboptimal infant Immune Development, AS a result of a Nutrient-deficient fetal environment, MAY lead to reduced Antibody response to routine childhood vaccines DUE TO the inadequate ability of the infant to mount an Immune Response.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 93), ('PROBLEM_COMPLICATION', 161)]	3	[('GO_0001822', 'kidney development', 18, 'immune development'), ('UBERON_0002405', 'immune system', 18, 'immune'), ('CHEBI_33284', 'nutrient', 55, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 113, 'antibody'), ('GO_0006955', 'immune response', 217, 'immune response'), ('UBERON_0002405', 'immune system', 217, 'immune')]	0	['suboptimal infant result nutrient-deficient fetal environment, antibody response routine childhood vaccines ability infant mount immune response.']
S11-PMC2721967	PMC2721967	7/2009	S11-PMC2721967	['RECENT RESEARCH SUGGESTS that nutritional status in early Life MAY IMPACT on Human Immune Development with, for example, a positive ASSOCIATION OBSERVED between Birth weight and Antibody response to certain vaccines later in Life (1–3).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 144)]	6	[('UBERON_0000104', 'life cycle', 58, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('GO_0001822', 'kidney development', 83, 'immune development'), ('UBERON_0002405', 'immune system', 83, 'immune'), ('GO_0007567', 'parturition', 161, 'birth'), ('GO_0042571', 'immunoglobulin complex, circulating', 178, 'antibody'), ('UBERON_0000104', 'life cycle', 225, 'life')]	0	['recent nutritional status life human  with, example, positive birth antibody response vaccines life (1–3).']
S0-PMC3016256	PMC3016256	12/2010	S0-PMC3016256	['epigenome targeting by Probiotic Metabolites\n\nabstract\n\nbackground\nthe Intestinal microbiota plays an IMPORTANT ROLE in Immune Development and Homeostasis.']	[('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 112)]	2	[('CHEBI_73033', 'pterocarpan', 23, 'probiotic'), ('CHEBI_25212', 'metabolite', 33, 'metabolites'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('GO_0001822', 'kidney development', 120, 'immune development'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0042592', 'homeostatic process', 143, 'homeostasis')]	0	['epigenome probiotic metabolites\n\nabstract\n\nbackground\nthe intestinal microbiota plays  homeostasis.']
S6-PMC3763666	PMC3763666	7/2012	S6-PMC3763666	['administration of Probiotics when a natural population of indigenous Intestinal bacteria is still developing COULD THEORETICALLY INFLUENCE Immune Development by favoring the balance between Th1 and Th2 Inflammatory Responses.']	[('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('CHEBI_26346', 'prostaglandins J', 18, 'probiotics'), ('UBERON_0000160', 'intestine', 69, 'intestinal'), ('GO_0001822', 'kidney development', 139, 'immune development'), ('UBERON_0002405', 'immune system', 139, 'immune'), ('GO_0042639', 'telogen', 190, 'Th1 ...'), ('GO_0001913', 'T cell mediated cytotoxicity', 198, 'Th2 inflammatory responses')]	0	['administration probiotics natural population indigenous intestinal bacteria  balance th1 th2 inflammatory responses.']
S172-PMC2658734	PMC2658734	4/2009	S172-PMC2658734	['Wnt/Β-Catenin Signalling Regulates the early events of Nephrogenic induction during Mouse Kidney Development [76]; HOWEVER, a Regulatory ROLE for mir-15 or -16 has NOT YET been DEMONSTRATED during this process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('SUPERFICIAL_RELATIONSHIP', 137), ('FULL_UNKNOWN', 164), ('INCOMPLETE_EVIDENCE', 177)]	4	[('GO_0016055', 'Wnt signaling pathway', 0, 'Wnt ... signalling'), ('PR_000002198', 'catenin beta-1', 4, 'β-catenin'), ('GO_0065007', 'biological regulation', 25, 'regulates'), ('GO_0001822', 'kidney development', 55, 'nephrogenic'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'mouse'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('GO_0065007', 'biological regulation', 126, 'regulatory')]	0	['wnt/β-catenin signalling events  induction mouse  [76]; however, mir-15 -16 process.']
S64-PMC2994393	PMC2994393	8/2010	S64-PMC2994393	['in Rats, Nephrogenesis is completed before Birth, BUT Renal differentiation and maturation continue Postnatally [14,15].']	[('ANOMALY_CURIOUS_FINDING', 50)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('GO_0001822', 'kidney development', 9, 'nephrogenesis'), ('GO_0007567', 'parturition', 43, 'birth'), ('UBERON_0002113', 'kidney', 54, 'renal'), ('GO_0007565', 'female pregnancy', 100, 'postnatally')]	0	['rats,  completed birth, renal maturation postnatally [14,15].']
S156-PMC3240629	PMC3240629	12/2011	S156-PMC3240629	['studies have also REVEALED impairments in Nephrogenesis in Rat offspring from lpd dams programming hypertension[44], whilst Aortic stiffness, reduced Vascular Smooth Muscle Cell number, Endothelial dysfunction and decreased Kidney Na+-K+-atpase activity HAVE BEEN REPORTED following maternal over nutrition[45].']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 254)]	2	[('GO_0001822', 'kidney development', 42, 'nephrogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 59, 'rat'), ('UBERON_0000947', 'aorta', 124, 'aortic'), ('CL_0000359', 'vascular associated smooth muscle cell', 150, 'vascular smooth muscle cell'), ('UBERON_0001135', 'smooth muscle tissue', 159, 'smooth muscle'), ('UBERON_0001986', 'endothelium', 186, 'endothelial'), ('UBERON_0002113', 'kidney', 224, 'kidney'), ('CHEBI_28741', 'sodium fluoride', 231, 'Na+-'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 235, 'K+-')]	0	['studies impairments  rat offspring lpd dams programming hypertension[44], aortic stiffness, vascular smooth muscle cell number, endothelial dysfunction decreased kidney na+-k+-atpase activity following maternal nutrition[45].']
S187-PMC3268605	PMC3268605	8/2011	S187-PMC3268605	['IN CONTRAST, our data SUGGEST that a decrease of Ribosome Biogenesis during a CRITICAL period of Nephrogenesis results in permanent physiologic changes to the Kidney, which in turn ameliorate the hypertension phenotype late in Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 78)]	3	[('GO_0005840', 'ribosome', 49, 'ribosome'), ('GO_0042254', 'ribosome biogenesis', 49, 'ribosome biogenesis'), ('GO_0001822', 'kidney development', 97, 'nephrogenesis'), ('UBERON_0002113', 'kidney', 159, 'kidney'), ('UBERON_0000104', 'life cycle', 227, 'life')]	0	['contrast, decrease ribosome biogenesis period  results permanent physiologic changes kidney, turn ameliorate hypertension phenotype late life.']
S17-PMC3290837	PMC3290837	10/2011	S17-PMC3290837	['THUS, the Postnatal environment COULD AFFECT Renal Development in premature infants Born before Nephrogenesis has been completed and for several days after Birth in Rats.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('GO_0007567', 'parturition', 10, 'postnatal'), ('GO_0060041', 'retina development in camera-type eye', 45, 'renal development'), ('UBERON_0002113', 'kidney', 45, 'renal'), ('GO_0007567', 'parturition', 84, 'born'), ('GO_0001822', 'kidney development', 96, 'nephrogenesis'), ('GO_0007567', 'parturition', 156, 'birth'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 165, 'rats')]	0	['thus, postnatal environment renal premature infants born  completed days birth rats.']
S10-PMC3424155	PMC3424155	8/2012	S10-PMC3424155	['conclusion\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D deficiency accompanies changes in the Renal Expression of IMPORTANT FACTORS that MAY retard the Maturation Of Glomeruli by EXTENDING the period of Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('IMPORTANT_CONSIDERATION', 120), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002113', 'kidney', 100, 'renal'), ('GO_0010467', 'gene expression', 106, 'expression'), ('GO_0009902', 'chloroplast relocation', 158, 'maturation of glomeruli'), ('UBERON_0000074', 'renal glomerulus', 172, 'glomeruli'), ('GO_0001822', 'kidney development', 209, 'nephrogenesis')]	0	['conclusion\nthese maternal vitamin accompanies changes renal expression retard maturation glomeruli period .']
S22-PMC3424155	PMC3424155	8/2012	S22-PMC3424155	['therefore, the adverse EFFECTS of Vitamin D restriction during Kidney Development NEED FURTHER exploration.']	[('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0001822', 'kidney development', 63, 'kidney development'), ('UBERON_0002113', 'kidney', 63, 'kidney')]	0	['therefore, vitamin  exploration.']
S167-PMC3424155	PMC3424155	8/2012	S167-PMC3424155	['in the PRESENT STUDY, maternal Vitamin D deficiency in Mice LED TO significant changes in Kidney Development in the offspring, such as retardation of Glomerular Maturation and an increase in the number of Glomeruli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 150, 'glomerular'), ('GO_0007618', 'mating', 161, 'maturation'), ('UBERON_0000074', 'renal glomerulus', 205, 'glomeruli')]	0	['study, maternal vitamin mice changes  offspring, retardation glomerular maturation increase glomeruli.']
S182-PMC3424155	PMC3424155	8/2012	S182-PMC3424155	['experimental MODELS have DEMONSTRATED that blocking the ras during development causes changes in the Glomerular Vasculature that AFFECTS the normal maturity of the Kidney, ALTHOUGH the ras cascade during Kidney Development is NOT FULLY UNDERSTOOD[28],[29].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 129), ('ANOMALY_CURIOUS_FINDING', 172), ('INCOMPLETE_EVIDENCE', 226)]	5	[('UBERON_0004190', 'renal glomerulus vasculature', 101, 'glomerular vasculature'), ('UBERON_0002113', 'kidney', 164, 'kidney'), ('GO_0001822', 'kidney development', 204, 'kidney development'), ('UBERON_0002113', 'kidney', 204, 'kidney')]	0	['experimental blocking ras causes changes glomerular vasculature kidney, ras cascade  understood[28],[29].']
S212-PMC3424155	PMC3424155	8/2012	S212-PMC3424155	['maternal Vitamin D deficiency is ACCOMPANIED by changes in the Renal Expression of Podocin, Renin and at1 receptors, and it delays the maturity of the Glomeruli, by EXTENDING Nephrogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002113', 'kidney', 63, 'renal'), ('GO_0010467', 'gene expression', 69, 'expression'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 83, 'podocin'), ('PR_000014368', 'RuvB-like 1', 92, 'renin'), ('UBERON_0000074', 'renal glomerulus', 151, 'glomeruli'), ('GO_0001822', 'kidney development', 175, 'nephrogenesis')]	0	['maternal vitamin changes renal expression podocin, renin at1 receptors, delays maturity glomeruli, .']
S10-PMC3458940	PMC3458940	9/2012	S10-PMC3458940	['such a catalogue will guide FURTHER STUDIES on molecular mediators of endogenous tra/rars during Kidney Development and in RELATION to Renal defects ASSOCIATED with Vitamin A deficiency.']	[('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('GO_0001822', 'kidney development', 97, 'kidney development'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002113', 'kidney', 135, 'renal'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin A')]	0	['catalogue molecular endogenous tra/rars  renal defects vitamin deficiency.']
S25-PMC3458940	PMC3458940	9/2012	S25-PMC3458940	['initially batourina et al PROPOSED that Kidney Stromal Mesenchyme is the primary site of action for tra/rar signaling in Embryonic Kidneys; the signal being delivered to the ub to Regulate ret Expression, which stimulates Ureteric Bud branching and initiates Kidney Development[11].']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('CL_1000606', 'kidney nerve cell', 40, 'kidney'), ('UBERON_0001228', 'renal papilla', 40, 'kidney stromal'), ('UBERON_0003104', 'mesenchyme', 55, 'mesenchyme'), ('UBERON_0000922', 'embryo', 121, 'embryonic'), ('UBERON_0002113', 'kidney', 131, 'kidneys'), ('GO_0065007', 'biological regulation', 180, 'regulate'), ('GO_0010467', 'gene expression', 193, 'expression'), ('UBERON_0000084', 'ureteric bud', 222, 'ureteric bud'), ('GO_0001822', 'kidney development', 259, 'kidney development'), ('UBERON_0002113', 'kidney', 259, 'kidney')]	0	['initially batourina et al kidney stromal mesenchyme site tra/rar signaling embryonic kidneys; signal delivered ub regulate ret expression, stimulates ureteric bud branching initiates [11].']
S3-PMC3482177	PMC3482177	10/2012	S3-PMC3482177	['HOWEVER, the mechanistic pathway leading from iron deficiency to fetal Kidney Development REMAINS ELUSIVE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 90)]	2	[('GO_0001822', 'kidney development', 71, 'kidney development'), ('UBERON_0002113', 'kidney', 71, 'kidney')]	0	['however, mechanistic iron fetal  elusive.']
S2-PMC3749995	PMC3749995	8/2013	S2-PMC3749995	['using a combination of in vitro and in vivo approaches we TESTED WHETHER increased maternal Salt Intake INFLUENCES fetal Kidney Development to render the Adult Individual more susceptible to salt retention and hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_24866', 'salt', 92, 'salt'), ('GO_0007631', 'feeding behavior', 97, 'intake'), ('GO_0001822', 'kidney development', 121, 'kidney development'), ('UBERON_0002113', 'kidney', 121, 'kidney'), ('UBERON_0007023', 'adult organism', 154, 'adult'), ('NCBITaxon_1', 'root', 160, 'individual')]	0	['using combination vivo maternal salt intake fetal  adult individual salt retention hypertension.']
S208-PMC3749995	PMC3749995	8/2013	S208-PMC3749995	['in vivo , fetal Plasma is not influenced by maternal Salt diet; HENCE fetal Kidney Development under these conditions is APPARENTLY normal, resultant Adult Kidney function is also relatively normal with no tendency for greater Salt retention to explain persistent hypernatraemia and hypertension in Salt-exposed male offspring.']	[('PROBABLE_UNDERSTANDING', 64), ('ANOMALY_CURIOUS_FINDING', 121)]	2	[('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_24866', 'salt', 53, 'salt'), ('GO_0001822', 'kidney development', 76, 'kidney development'), ('UBERON_0002113', 'kidney', 76, 'kidney'), ('UBERON_0007023', 'adult organism', 150, 'adult'), ('UBERON_0002113', 'kidney', 156, 'kidney'), ('CHEBI_24866', 'salt', 227, 'salt'), ('CHEBI_24866', 'salt', 299, 'salt')]	0	['vivo fetal plasma maternal salt diet; fetal  conditions normal, resultant adult kidney normal salt retention hypernatraemia hypertension salt-exposed male offspring.']
S220-PMC3749995	PMC3749995	8/2013	S220-PMC3749995	['elevated Plasma osmolality is more commonly ASSOCIATED with diabetes insipidus (di) in which EITHER Production Of Avp is lacking (central di) or Kidneys are insensitive to avp (Nephrogenic di)[27]; each of which increases free Water clearance and sufferers of di are characteristically polyuric and polydipsic.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	2	[('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('GO_0006754', 'ATP biosynthetic process', 100, 'production of AVP'), ('UBERON_0002113', 'kidney', 145, 'kidneys'), ('GO_0001822', 'kidney development', 177, 'nephrogenic'), ('CHEBI_15377', 'water', 227, 'water')]	0	['elevated plasma osmolality diabetes insipidus (di) production avp (central di) kidneys avp di)[27]; water clearance sufferers di characteristically polyuric polydipsic.']
S279-PMC3749995	PMC3749995	8/2013	S279-PMC3749995	['the prevailing scientific literature SUGGESTS programming of Kidney Development and function PRIMARILY UNDERPINS this phenotype.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 93), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0001822', 'kidney development', 61, 'kidney development'), ('UBERON_0002113', 'kidney', 61, 'kidney')]	0	['programming  phenotype.']
S46-PMC3773449	PMC3773449	8/2013	S46-PMC3773449	['in Animals, maternal diabetes, maternal obesity, and fetal exposure to Drugs CAN alter Nephrogenesis and impair Renal function on the long term.']	[('INCOMPLETE_EVIDENCE', 77)]	1	[('NCBITaxon_33208', 'Metazoa', 3, 'animals'), ('CHEBI_23888', 'drug', 71, 'drugs'), ('GO_0001822', 'kidney development', 87, 'nephrogenesis'), ('UBERON_0002113', 'kidney', 112, 'renal')]	0	['animals, maternal diabetes, maternal obesity, fetal exposure drugs alter  renal term.']
S123-PMC3773449	PMC3773449	8/2013	S123-PMC3773449	['data from autopsy studies which included Kidneys from preterm infants who died during the Neonatal Period at different Gestational and Postnatal ages SHOWED SIGNS of accelerated maturation of Nephrogenesis with enlarged Glomeruli [104,105].']	[('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 157)]	2	[('UBERON_0002113', 'kidney', 41, 'kidneys'), ('UBERON_0007221', 'neonate stage', 90, 'neonatal period'), ('GO_0007565', 'female pregnancy', 119, 'gestational'), ('GO_0007567', 'parturition', 135, 'postnatal'), ('GO_0001822', 'kidney development', 192, 'nephrogenesis'), ('UBERON_0000074', 'renal glomerulus', 220, 'glomeruli')]	0	['data autopsy kidneys preterm infants died neonatal period gestational postnatal ages accelerated maturation  enlarged glomeruli [104,105].']
S176-PMC3773449	PMC3773449	8/2013	S176-PMC3773449	['in most cases, alterations in Nephrogenesis are subtle and are PROBABLY not responsible by themselves to chronic Kidney disease.']	[('PROBABLE_UNDERSTANDING', 63)]	1	[('GO_0001822', 'kidney development', 30, 'nephrogenesis'), ('UBERON_0002113', 'kidney', 113, 'kidney')]	0	['cases, alterations  subtle chronic kidney disease.']
S19-PMC4284764	PMC4284764	12/2014	S19-PMC4284764	['the Kidney is particularly susceptible to the insults of programming during Nephrogenesis and HAS BEEN identified as a key player in programmed hypertension [13].']	[('INCOMPLETE_EVIDENCE', 94)]	1	[('UBERON_0002113', 'kidney', 4, 'kidney'), ('GO_0001822', 'kidney development', 76, 'nephrogenesis')]	0	['kidney insults programming  player programmed hypertension [13].']
S7-PMC4377888	PMC4377888	3/2015	S7-PMC4377888	['IMPORTANTLY, to date, the literature offers LITTLE TO NO UNDERSTANDING of WHEN in development these changes in Kidney Development occur, nor are the cellular and molecular mechanisms that DRIVE these changes well characterised.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 44), ('INCOMPLETE_EVIDENCE', 44), ('EXPLICIT_QUESTION', 74), ('SUPERFICIAL_RELATIONSHIP', 188)]	5	[('GO_0001822', 'kidney development', 111, 'kidney development'), ('UBERON_0002113', 'kidney', 111, 'kidney')]	0	['importantly, date, offers changes  occur, cellular molecular mechanisms changes characterised.']
S9-PMC4377888	PMC4377888	3/2015	S9-PMC4377888	['THIS REVIEW will FOCUS on RECENT INFORMATION on POTENTIAL mechanisms by which maternal nutrition (FOCUSING on malnutrition due to protein restriction, Micronutrient restriction and excessive fat intake) INFLUENCES Kidney Development and thereby function in later Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 203)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 151, 'micronutrient'), ('GO_0001822', 'kidney development', 214, 'kidney development'), ('UBERON_0002113', 'kidney', 214, 'kidney'), ('UBERON_0000104', 'life cycle', 263, 'life')]	0	['mechanisms maternal nutrition (focusing malnutrition protein restriction, micronutrient excessive fat intake)  life.']
S21-PMC4377888	PMC4377888	3/2015	S21-PMC4377888	['THIS PAPER will review the literature to describe the ROLE of maternal macro- and micro-Nutrient imbalance in INFLUENCING Fetal and Neonatal Kidney Development, final Nephron complement and the EFFECT of these structural abnormalities on Adult function.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 110), ('SUPERFICIAL_RELATIONSHIP', 194)]	4	[('CHEBI_33284', 'nutrient', 88, 'nutrient'), ('GO_0007631', 'feeding behavior', 122, 'fetal ...'), ('GO_0007567', 'parturition', 132, 'neonatal'), ('GO_0001822', 'kidney development', 141, 'kidney development'), ('UBERON_0002113', 'kidney', 141, 'kidney'), ('UBERON_0001285', 'nephron', 167, 'nephron'), ('UBERON_0007023', 'adult organism', 238, 'adult')]	0	['maternal macro- micro-nutrient fetal neonatal final nephron structural abnormalities adult function.']
S25-PMC4377888	PMC4377888	3/2015	S25-PMC4377888	['for example, the EFFECTS of maternal dietary zinc, Vitamin A and protein restriction or maternal dietary fat excess all HAVE BEEN SHOWN to have a negative IMPACT on Kidney Development and later Renal disease in the offspring [16,17,18,19].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0001822', 'kidney development', 165, 'kidney development'), ('UBERON_0002113', 'kidney', 165, 'kidney'), ('UBERON_0002113', 'kidney', 194, 'renal')]	0	['example, maternal dietary zinc, vitamin protein maternal dietary fat excess  renal disease offspring [16,17,18,19].']
S44-PMC4377888	PMC4377888	3/2015	S44-PMC4377888	['the variability in phenotype MAY BE resultant from exposure to dietary insult at different points of Kidney Development.']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('GO_0001822', 'kidney development', 101, 'kidney development'), ('UBERON_0002113', 'kidney', 101, 'kidney')]	0	['phenotype resultant exposure dietary insult .']
S45-PMC4377888	PMC4377888	3/2015	S45-PMC4377888	['knowledge of the molecular processes INVOLVED in Controlling Kidney Development and ultimately Adult morphology are ESSENTIAL for understanding the IMPACT of maternal protein restriction and will be discussed in further detail later in the review.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 148)]	3	[('GO_0065007', 'biological regulation', 49, 'controlling'), ('GO_0001822', 'kidney development', 61, 'kidney development'), ('UBERON_0002113', 'kidney', 61, 'kidney'), ('UBERON_0007023', 'adult organism', 95, 'adult')]	0	['knowledge molecular processes controlling  adult morphology maternal protein detail review.']
S68-PMC4377888	PMC4377888	3/2015	S68-PMC4377888	['the mechanism UNDERLYING this abnormal Kidney phenotype is MOST LIKELY the fact the Vitamin A is a key ligand for the cret receptor, which Controls the earliest processes of Kidney Development (seesection 2for full details).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('UBERON_0002113', 'kidney', 39, 'kidney'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'controls'), ('GO_0001822', 'kidney development', 174, 'kidney development'), ('UBERON_0002113', 'kidney', 174, 'kidney')]	0	['abnormal kidney phenotype vitamin ligand cret receptor, processes  (seesection 2for details).']
S72-PMC4377888	PMC4377888	3/2015	S72-PMC4377888	['the pathway by which different Micronutrient deficiency LEADS TO similar morphological phenotypes REMAINS UNKNOWN; zinc deficiency has negative EFFECTS on Branching Morphogenesis; a process key to Kidney Development, BUT CAN also IMPACT upon the Development Of the Placenta, thereby AFFECTING the growth potential of the entire Embryo or fetus [58].']	[('SUPERFICIAL_RELATIONSHIP', 56), ('FULL_UNKNOWN', 98), ('SUPERFICIAL_RELATIONSHIP', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 217), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 31, 'micronutrient'), ('GO_0001763', 'morphogenesis of a branching structure', 155, 'branching morphogenesis'), ('GO_0001822', 'kidney development', 197, 'kidney development'), ('UBERON_0002113', 'kidney', 197, 'kidney'), ('GO_0001889', 'liver development', 246, 'development of ... placenta'), ('UBERON_0001987', 'placenta', 265, 'placenta'), ('UBERON_0000922', 'embryo', 328, 'embryo')]	0	['micronutrient morphological phenotypes unknown; zinc branching morphogenesis; process placenta, entire embryo fetus [58].']
S74-PMC4377888	PMC4377888	3/2015	S74-PMC4377888	['this PROMPTS the HYPOTHESIS that fundamental processes in Kidney Development MAY BE sensitive to an array of abnormal signals from the environment, eliciting a common Adaptive response and resulting in a characteristic phenotype.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 77)]	3	[('GO_0001822', 'kidney development', 58, 'kidney development'), ('UBERON_0002113', 'kidney', 58, 'kidney'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 167, 'adaptive')]	0	['processes  sensitive array abnormal signals environment, eliciting adaptive response resulting phenotype.']
S105-PMC4377888	PMC4377888	3/2015	S105-PMC4377888	['tight Regulation Of Branching Morphogenesis is ESSENTIAL to both Kidney Development and function.']	[('IMPORTANT_CONSIDERATION', 47)]	1	[('GO_0007565', 'female pregnancy', 6, 'regulation of'), ('GO_0001763', 'morphogenesis of a branching structure', 20, 'branching morphogenesis'), ('GO_0001822', 'kidney development', 65, 'kidney development'), ('UBERON_0002113', 'kidney', 65, 'kidney')]	0	['tight branching morphogenesis  function.']
S147-PMC4377888	PMC4377888	3/2015	S147-PMC4377888	['IMPORTANTLY, once Kidney Development is complete (at around Gestational week 38 in Humans and Postnatal day 8 in Rat), no further Nephrons are formed.']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0001822', 'kidney development', 18, 'kidney development'), ('UBERON_0002113', 'kidney', 18, 'kidney'), ('GO_0007565', 'female pregnancy', 60, 'gestational'), ('NCBITaxon_9606', 'Homo sapiens', 83, 'humans'), ('GO_0007567', 'parturition', 94, 'postnatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 113, 'rat'), ('UBERON_0001285', 'nephron', 130, 'nephrons')]	0	['importantly,  (at gestational week 38 humans postnatal day 8 rat), nephrons formed.']
S148-PMC4377888	PMC4377888	3/2015	S148-PMC4377888	['THEREFORE, a reduction in Nephron number caused by interventions during Kidney Development persists throughout Life and MAY CONTRIBUTE to the BURDEN of disease in later Life.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 142)]	4	[('UBERON_0001285', 'nephron', 26, 'nephron'), ('GO_0001822', 'kidney development', 72, 'kidney development'), ('UBERON_0002113', 'kidney', 72, 'kidney'), ('UBERON_0000104', 'life cycle', 111, 'life'), ('UBERON_0000104', 'life cycle', 169, 'life')]	0	['therefore, reduction nephron  persists throughout life disease life.']
S150-PMC4377888	PMC4377888	3/2015	S150-PMC4377888	[', 2007 SHOWED in Rats that Glucocorticoid exposure during the early stages of Kidney Development (Embryonic day e14 to e15), permanently decreased Nephron number at pn30 [98].']	[('INCOMPLETE_EVIDENCE', 7)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 17, 'rats'), ('CHEBI_24261', 'glucocorticoid', 27, 'glucocorticoid'), ('GO_0001822', 'kidney development', 78, 'kidney development'), ('UBERON_0002113', 'kidney', 78, 'kidney'), ('UBERON_0000922', 'embryo', 98, 'embryonic'), ('UBERON_0001285', 'nephron', 147, 'nephron')]	0	[', 2007 rats glucocorticoid exposure stages  (embryonic day e14 e15), permanently decreased nephron pn30 [98].']
S156-PMC4377888	PMC4377888	3/2015	S156-PMC4377888	['additionally, Uteroplacental insufficiency and reduction in litter number has SIMILAR EFFECT during the late stage Kidney Development [107,108].']	[('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('UBERON_0012469', 'external anal region', 14, 'uteroplacental'), ('GO_0001822', 'kidney development', 115, 'kidney development'), ('UBERON_0002113', 'kidney', 115, 'kidney')]	0	['additionally, uteroplacental reduction litter late  [107,108].']
S201-PMC4377888	PMC4377888	3/2015	S201-PMC4377888	['FEW STUDIES have investigated the ROLE of epigenetics in Kidney Development HOWEVER there is STRONG EVIDENCE that relatively high level ( i.e.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 93)]	4	[('GO_0001822', 'kidney development', 57, 'kidney development'), ('UBERON_0002113', 'kidney', 57, 'kidney')]	0	['epigenetics  i.e.']
S202-PMC4377888	PMC4377888	3/2015	S202-PMC4377888	[', changes to enzymes that have wide-reaching EFFECTS, RATHER than those that Control a particular process of Kidney Development) epigenetic changes MAY drive later Kidney disease.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('INCOMPLETE_EVIDENCE', 148)]	3	[('GO_0065007', 'biological regulation', 77, 'control'), ('GO_0001822', 'kidney development', 109, 'kidney development'), ('UBERON_0002113', 'kidney', 109, 'kidney'), ('UBERON_0002113', 'kidney', 164, 'kidney')]	0	[', changes enzymes wide-reaching effects, process epigenetic changes kidney disease.']
S206-PMC4377888	PMC4377888	3/2015	S206-PMC4377888	['the IMPORTANCE of Dicer; the enzyme which cleaves Non-Coding Micrornas into active Micrornas during Mammalian Kidney Development HAS BEEN SHOWN by nagalakshmi et al.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 129)]	2	[('PR_000006305', 'dermcidin', 18, 'Dicer'), ('SO_0000478', 'C_gene_segment', 50, 'non-coding'), ('SO_0000276', 'miRNA', 61, 'microRNAs'), ('SO_0000276', 'miRNA', 83, 'microRNAs'), ('NCBITaxon_40674', 'Mammalia', 100, 'mammalian'), ('GO_0001822', 'kidney development', 110, 'kidney development'), ('UBERON_0002113', 'kidney', 110, 'kidney')]	0	['dicer; enzyme cleaves non-coding micrornas micrornas mammalian  nagalakshmi et al.']
S214-PMC4377888	PMC4377888	3/2015	S214-PMC4377888	['these results ILLUSTRATE the IMPORTANCE of Mirna function during Kidney Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('IMPORTANT_CONSIDERATION', 29)]	2	[('SO_0000276', 'miRNA', 43, 'miRNA'), ('GO_0001822', 'kidney development', 65, 'kidney development'), ('UBERON_0002113', 'kidney', 65, 'kidney')]	0	['results mirna .']
S288-PMC4377888	PMC4377888	3/2015	S288-PMC4377888	['THIS STUDY INDICATES that dietary IMPACT at DIFFERENT time points indeed COULD AFFECT Kidney Development through DIFFERENT pathways.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	7	[('GO_0001822', 'kidney development', 86, 'kidney development'), ('UBERON_0002113', 'kidney', 86, 'kidney')]	0	['dietary  pathways.']
S291-PMC4377888	PMC4377888	3/2015	S291-PMC4377888	['post-Natal Nutritional planes have DIFFERING EFFECTS on Kidney Development in altricial species such as Rats and Mice.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0007567', 'parturition', 5, 'natal'), ('CHEBI_7495', 'nefazodone hydrochloride', 11, 'nutritional'), ('GO_0001822', 'kidney development', 56, 'kidney development'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 104, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 113, 'mice')]	0	['post-natal nutritional planes  altricial species rats mice.']
S305-PMC4377888	PMC4377888	3/2015	S305-PMC4377888	['INVESTIGATING the IMPACT of Preterm Birth in Humans on Kidney Development and function, gubhaju et al.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('GO_0007565', 'female pregnancy', 28, 'preterm birth'), ('NCBITaxon_9606', 'Homo sapiens', 45, 'humans'), ('GO_0001822', 'kidney development', 55, 'kidney development'), ('UBERON_0002113', 'kidney', 55, 'kidney')]	0	['investigating preterm birth humans  function, gubhaju et al.']
S308-PMC4377888	PMC4377888	3/2015	S308-PMC4377888	['(2011) report that WHILE there is a Renal maturation in infants Born preterm (before the cessation of Nephrogenesis) this accelerated maturation is ASSOCIATED with morphologically small Glomeruli [161].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('SUPERFICIAL_RELATIONSHIP', 148)]	2	[('UBERON_0002113', 'kidney', 36, 'renal'), ('GO_0007567', 'parturition', 64, 'born'), ('GO_0001822', 'kidney development', 102, 'nephrogenesis'), ('UBERON_0000074', 'renal glomerulus', 186, 'glomeruli')]	0	['(2011) renal maturation infants born preterm (before cessation accelerated maturation morphologically glomeruli [161].']
S316-PMC4377888	PMC4377888	3/2015	S316-PMC4377888	['it remains to be discovered WHEN the maternal diet INFLUENCES Kidney Development, WHAT molecular processes are effected and IF the phenotype can be rescued or halted.']	[('EXPLICIT_QUESTION', 28), ('SUPERFICIAL_RELATIONSHIP', 51), ('EXPLICIT_QUESTION', 82), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	4	[('GO_0001822', 'kidney development', 62, 'kidney development'), ('UBERON_0002113', 'kidney', 62, 'kidney')]	0	['maternal diet molecular processes phenotype halted.']
S163-PMC4699824	PMC4699824	12/2015	S163-PMC4699824	['clearly, one cannot administer angiotensin converting enzyme Inhibitor or angiotensin ii receptor Blockers during Nephrogenesis in very premature infants BECAUSE of the IMPORTANCE of the Renin angiotensin system in Renal Development [46,47].']	[('PROBLEM_COMPLICATION', 154), ('IMPORTANT_CONSIDERATION', 169)]	2	[('CHEBI_35222', 'inhibitor', 61, 'inhibitor'), ('CHEBI_35225', 'buffer', 98, 'blockers'), ('GO_0001822', 'kidney development', 114, 'nephrogenesis'), ('PR_000014368', 'RuvB-like 1', 187, 'renin'), ('GO_0060041', 'retina development in camera-type eye', 215, 'renal development'), ('UBERON_0002113', 'kidney', 215, 'renal')]	0	['clearly, administer angiotensin converting enzyme inhibitor angiotensin ii receptor blockers  premature infants renin angiotensin system renal [46,47].']
S23-PMC4924183	PMC4924183	6/2016	S23-PMC4924183	['wood-bradley and team provide a review of the literature surrounding the POTENTIAL mechanisms by which maternal nutrition (focusing on malnutrition due to protein restriction, Micronutrient restriction and excessive fat intake) INFLUENCES offspring Kidney Development and thereby function in later Life [8].']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 228)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 176, 'micronutrient'), ('GO_0001822', 'kidney development', 249, 'kidney development'), ('UBERON_0002113', 'kidney', 249, 'kidney'), ('UBERON_0000104', 'life cycle', 298, 'life')]	0	['wood-bradley team surrounding mechanisms maternal nutrition (focusing malnutrition protein restriction, micronutrient excessive fat intake) offspring  life [8].']
S80-PMC5187820	PMC5187820	12/2016	S80-PMC5187820	['GIVEN that No Regulates many physiological functions, it is NOT SURPRISING that several IMPORTANT biological pathways are Regulated by adma in the developing Kidney during Nephrogenesis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 60), ('ANOMALY_CURIOUS_FINDING', 64), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_16382', 'iodide', 11, 'NO'), ('GO_0065007', 'biological regulation', 14, 'regulates'), ('GO_0065007', 'biological regulation', 122, 'regulated'), ('UBERON_0002113', 'kidney', 158, 'kidney'), ('GO_0001822', 'kidney development', 172, 'nephrogenesis')]	0	['given physiological functions, biological adma kidney .']
S229-PMC5303734	PMC5303734	2/2017	S229-PMC5303734	['there is CONSISTENT with the OBSERVATIONS in Kidney Development and function in the same cohort of se offspring (nguyen et al.,2015).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29)]	2	[('GO_0001822', 'kidney development', 45, 'kidney development'), ('UBERON_0002113', 'kidney', 45, 'kidney')]	0	[' se offspring (nguyen et al.,2015).']
S126-PMC3156327	PMC3156327	4/2011	S126-PMC3156327	['exposure to tobacco smoke and air Pollutants\ncigarette smoke and inhaled Pollutants have RECOGNISED adverse EFFECTS in Pregnancy, including EFFECTS on foetal Lung growth (gilliland et al.2000) and Immune Development (noakes et al.2003).']	[('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_26199', 'polyprenol', 34, 'pollutants'), ('CHEBI_26199', 'polyprenol', 73, 'pollutants'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0002048', 'lung', 158, 'lung'), ('GO_0001822', 'kidney development', 197, 'immune development'), ('UBERON_0002405', 'immune system', 197, 'immune')]	0	['exposure tobacco smoke air pollutants\ncigarette smoke inhaled pollutants pregnancy, foetal lung (gilliland et al.2000)  (noakes et al.2003).']
S141-PMC5659607	PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]	0	['addition, human fertility vitamin d[29,30], supplementation optimize implantation fertilized egg assure vitamin lung  life.']
S255-PMC4448820	PMC4448820	5/2015	S255-PMC4448820	['in particular, Nk T Cell Development in Mice is CRITICALLY DEPENDENT on Vitamin D (173).']	[('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CL_0000213', 'lining cell', 15, 'NK T cell'), ('GO_0001822', 'kidney development', 15, 'NK T cell development'), ('GO_0005634', 'nucleus', 15, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]	0	['particular,  mice vitamin (173).']
S379-PMC4448820	PMC4448820	5/2015	S379-PMC4448820	['the ESSENTIALITY of Vitamin D in Regulating invariant invariant Nk T Cell Development in Mice IS THOUGHT TO be via epigenetic mechanisms (173).']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulating'), ('CL_0000213', 'lining cell', 64, 'NK T cell'), ('GO_0001822', 'kidney development', 64, 'NK T cell development'), ('GO_0005634', 'nucleus', 64, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice')]	0	['vitamin invariant invariant  mice via epigenetic mechanisms (173).']
S59-PMC3488908	PMC3488908	4/2010	S59-PMC3488908	['Animal studies SUGGEST that resting Dc stimulate th2 Immune Development unless they receive obligatory th1-trophic signals during Antigen Processing.30these signals MAY occur under conditions of infection or OTHER local stress,31,32which evoke protective Th1 Effector T-Cell Responses.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CL_0000784', 'plasmacytoid dendritic cell', 36, 'DC'), ('GO_0001822', 'kidney development', 53, 'immune development'), ('UBERON_0002405', 'immune system', 53, 'immune'), ('CHEBI_59132', 'antigen', 130, 'antigen'), ('GO_0008306', 'associative learning', 130, 'antigen processing'), ('GO_0033080', 'immature T cell proliferation in thymus', 255, 'TH1 ... T-cell responses'), ('CHEBI_35224', 'effector', 259, 'effector'), ('CL_0000911', 'effector T cell', 259, 'effector T-cell')]	0	['animal resting dc th2  receive obligatory th1-trophic signals antigen processing.30these signals occur conditions infection local stress,31,32which th1 effector t-cell responses.']
S47-PMC5716389	PMC5716389	9/2017	S47-PMC5716389	['Folate, one of the b Complex Vitamins, WAS shown to be CRUCIAL for Cell Proliferation [33], Central Nervous System Cell Repair [34], appropriate epigenetic Expression of the Genome [35] and for Immune Development [36].']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55)]	2	[('CHEBI_81245', 'Vulpecholate', 0, 'Folate'), ('CHEBI_34652', 'compactin diol lactone', 21, 'complex'), ('GO_0032991', 'protein-containing complex', 21, 'complex'), ('CHEBI_33277', 'gamma-tocotrienol', 29, 'vitamins'), ('GO_0008283', 'cell proliferation', 67, 'cell proliferation'), ('CL_0002338', 'CD56-positive, CD161-positive immature natural killer cell, human', 92, 'central nervous system cell'), ('UBERON_0001017', 'central nervous system', 92, 'central nervous system'), ('GO_0008219', 'cell death', 115, 'cell repair'), ('GO_0010467', 'gene expression', 156, 'expression'), ('SO_0001026', 'genome', 174, 'genome'), ('GO_0001822', 'kidney development', 194, 'immune development'), ('UBERON_0002405', 'immune system', 194, 'immune')]	0	['folate, b vitamins, cell proliferation [33], central nervous system cell repair [34], epigenetic expression genome [35]  [36].']
S173-PMC4377888	PMC4377888	3/2015	S173-PMC4377888	['angiotensin is ESSENTIAL in forming Blood Vessels and Tubules during Nephrogenesis as well as the Development Of Smooth Muscle In the Ureter [116,117].']	[('IMPORTANT_CONSIDERATION', 15)]	1	[('UBERON_0001981', 'blood vessel', 36, 'blood vessels'), ('UBERON_0000025', 'tube', 54, 'tubules'), ('GO_0001822', 'kidney development', 69, 'nephrogenesis'), ('GO_0042748', 'circadian sleep/wake cycle, non-REM sleep', 98, 'development of smooth muscle in ... ureter'), ('UBERON_0001135', 'smooth muscle tissue', 113, 'smooth muscle'), ('UBERON_0000056', 'ureter', 134, 'ureter')]	0	['angiotensin forming blood vessels tubules  smooth muscle ureter [116,117].']
